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Abstract 
Background and Aims: Continuous epidural analgesia (CEA) and continuous spinal postoperative 
analgesia (CSPA) provided by a mixture of a local anaesthetic and an opioid are widely used for 
pain control after major surgery. These techniques, however, may be associated with dose-
dependent side-effects as hypotension, weakness in the legs, respiratory depression, and nausea and 
vomiting. At times, they may fail to offer sufficient analgesia, e.g., because of a misplaced catheter. 
The correct position of an epidural catheter might be confirmed during CEA by the supposedly easy 
and reliable epidural stimulation test (EST) (electrical neurostimulation). In the past years, CSPA 
found its way with the introduction of what is referred to as microcatheters, particularly in 
orthopaedic surgery. The aims of this thesis were to determine a) whether the efficacy, tolerability, 
and reliability of CEA might be improved by adding the α2-adrenergic agonists adrenaline 
(epinephrine) and clonidine to CEA, and by the repeated use of EST during CEA; and, b) the 
feasibility of CSPA given through a microcatheter after vascular surgery of the lower extremities. 
Patients and Methods: Studies I–IV were double-blinded, randomized, and controlled trials; Study 
V was of a diagnostic, prospective nature. Patients underwent arterial bypass surgery of the legs in 
Studies I (n=50) and IV (n=46), total knee arthroplasty in Studies II (n=70) and III (n=72), and 
abdominal surgery or thoracotomy in Study V (n=30). In Studies I–III, postoperative lumbar CEA 
consisted of regular mixtures of low-dose ropivacaine and fentanyl either without or with 
adrenaline (2 µg/ml in Study I and 4 µg/ml in Study II) and clonidine 2 µg/ml (Study III). In Study 
IV, CSPA was given through a microcatheter (28G) and contained either ropivacaine (max. 2 mg/h) 
or a mixture of ropivacaine (max. 1 mg/h) and morphine (max. 8 µg/h). In Study V, epidural 
catheter tip position was evaluated both by EST at the moment of catheter placement and several 
times during CEA, and by epidurography as reference diagnostic test. CEA and CSPA were 
administered for 24 h (III and IV) or 48 h (I, II, and V). Study parameters included pain scores 
assessed with a visual analogue scale, requirements of rescue pain medication, vital signs, and side-
effects.  
Results: Adrenaline (I and II) had no beneficial influence as regards the efficacy or tolerability of 
CEA. The total amounts of epidurally-infused drugs were even increased in the adrenaline group in 
Study II (p=0.02, RM ANOVA; mean inter-group difference 40 ml (95% CI 5–75 ml)). Clonidine 
(III) augmented pain relief with lowered amounts of epidurally infused drugs (p=0.01, RM 
ANOVA; mean inter-group difference 13 ml (95% CI 4–22 ml)) and reduced need for rescue 
oxycodone given i.m. (p=0.027, MW-U; median difference in oxycodone consumption 3 mg (95% 
CI 0–7 mg)). Clonidine did not contribute to sedation and its influence on haemodynamics was 
minimal. CSPA (IV) provided satisfactory pain relief with only limited blockade of the legs (no 
inter-group differences between the combination of low-dose ropivacaine and morphine compared 
to the higher ropivacaine concentration alone). EST (V) was often related to technical problems and 
difficulties of interpretation (e.g., need to flush the catheter with saline; influence of respiratory 
activity; EST failed to identify the four patients whose catheters were outside the spinal canal 
already at the time of catheter placement). 
Conclusions: As adjuvants to lumbar CEA, clonidine only slightly improved pain relief, while 
adrenaline did not provide any benefit. The role of EST applied at the time of epidural catheter 
placement or repeatedly during CEA remains open. The microcatheter CSPA technique appeared 
effective and reliable, but needs to be compared to CEA, the analgesia technique frequently used 
after peripheral arterial bypass surgery.  
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Abbreviations 
95% CI 95% confidence intervals 
ABPI Ankle-brachial blood pressure index 
ASA class American Society of Anesthesiologists physical status classification 
BMI Body mass index 
χ2 test Chi-square test 
CEA Continuous epidural analgesia 
CSA Continuous spinal anaesthesia 
CSF Cerebrospinal fluid 
CSPA Continuous spinal postoperative analgesia 
CVP Central venous pressure 
Day 0, 1, and 2 Day of surgery as well as first and second postoperative day, respectively 
ECG Electrocardiogram 
EDTA Ethylene diamine tetra-acetate 
EST Epidural stimulation test 
F F-ratio 
G Gauge, a measure to indicate the diameter of needles and catheters  
GA General anaesthesia 
i.m. Intramuscular 
i.v. Intravenous 
LEA Lumbar epidural analgesia 
LMWH Low-molecular weight heparin 
LOR Loss-of-resistance  
MAP Mean arterial pressure 
max. Maximum 
MW-U Mann-Whitney U test 
No., no., n Number 
NA Not assessed or not applicable 
NSAID Non-steroidal anti-inflammatory drug 
p p-value, probability 
PACU Postanaesthesia care unit 
PCA Patient controlled analgesia 
p.o. Per os 
PDPH Postdural puncture headache 
PHH-score Prince Henry Hospital pain score 
PONV Postoperative nausea and vomiting 
RCT Randomized controlled trial 
RM ANOVA Repeated-measurement analysis of variance 
s.c. Subcutaneous 
SD Standard deviation 
SpO2 Oxygen saturation measured by pulse oximetry  
SSA Single-dose spinal anaesthesia 
TEA Thoracic epidural analgesia 
TKA Total knee arthroplasty 
VAS Visual analogue scale 
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Introduction 
Epidural and intrathecal routes, also known as neuraxial routes, for the administration of drugs are 
used for the treatment of pain after surgery. This is in analogy to epidural and spinal anaesthesia 
during surgery where local anaesthetics are given close to the ‘target organ’, namely the spinal cord 
and nerve roots. Its aim is to deliver minimal yet effective drug doses with limited side-effects.  
The continuous epidural analgesia (CEA) technique has been used to offer analgesia following 
various surgical procedures. In a meta-analysis, Block et al. described epidural analgesia as 
providing better postoperative analgesia when compared to parenteral opioids [Block et al. 2003]. 
Epidural analgesia, however, does not always grant adequate pain relief. Of patients given 
postoperative epidural analgesia, 21% complained of moderate-severe pain while another 8% 
described their pain as being severe [Dolin et al. 2002]. Despite the many advances in pain 
management, postoperative pain remains an important cause of suffering [Apfelbaum et al. 2003].  
In the neuraxial techniques, where local anaesthetics and opioids are often combined [Walker 
et al. 2002], the provision of effective analgesia may be limited because of side-effects. Possible 
undesired effects associated with local anaesthetics are hypotension and weakness of the legs 
[Block et al. 2003]; when opioids are used, nausea and itching may result, as might depression of 
respiration [Breivik 1992; Block et al. 2003]. The frequency and grade of these side-effects are, to a 
large degree, dose-dependent. Therefore, in an attempt to lower the dosages, one may add other 
antinociceptive substances from different pharmacological classes to the mixture of the local 
anaesthetic and opioid. Such drug combinations may produce analgesia by additive or even 
synergistic (‘supra-additive’) mechanisms and permit smaller doses of each drug with 
correspondingly fewer dose-related side-effects.  
The list of adjuvant drugs studied in regional anaesthesia in recent years includes the α2-
adrenergic agonists adrenaline (epinephrine) and clonidine. Concerning α2-adrenergic agonists, 
Gordh stated [Gordh 1992] that treatment with clonidine and other α2-adrenoceptor agonists may 
represent an important new approach to neuraxial analgesia by carrying a lower risk of respiratory 
depression.  
Adrenaline has been employed as an adjuvant in regional anaesthesia for more than a century. 
The activity of adrenaline given epidurally is presumably due to its vasoconstrictive effect; local 
blood flow is decreased resulting in a slower rate of absorption and prolonging the effect of co-
administered drugs. Additionally, adrenaline possesses its own pharmacodynamic analgesic effect 
which is expressed through α2-adrenoreceptors in the dorsal horn of the spinal cord [Reddy et al. 
1980]. Adrenaline added to an infusion of an opioid and a local anaesthetic may be useful in 
improving thoracic CEA [Niemi and Breivik 1998] but its value in lumbar CEA remains 
contradictory [Curatolo 2002].  
Clonidine has been used as an adjuvant in connection with various regional anaesthesia 
techniques [Eisenach et al. 1996] including postoperative epidural analgesia [Armand et al. 1998]: 
In many studies, clonidine was combined with either a local anaesthetic or an opioid; however, 
there are only a limited number of studies in which clonidine was added to an epidural infusion 
containing both a local anaesthetic and an opioid.  
Regardless of which drug or drugs are given through an epidural catheter, analgesia will be 
inadequate if the tip of the catheter is not properly placed within the epidural space. The 
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identification of the epidural space using the routine loss-of-resistance technique [Bromage 1954; 
Bonica 1956] and the positioning of the epidural catheter largely rely on the feel and the dexterity 
of the anaesthetist but without visual control of the catheter position. Although the catheter may 
initially lie correctly within the epidural space, subsequently it may migrate to a less suitable level 
or even slip out of the epidural space. In one report, this incidence of premature catheter 
dislodgement was about 6% [Dolin et al. 2002].  
A potentially simple technique to confirm the position of the epidural catheter was described by 
Tsui and colleagues. They judged the location of the catheter to be correct on the basis of truncal or 
limb movement using electrical neurostimulation applied through the catheter (epidural stimulation 
test (EST)) [Tsui et al. 1998]. As yet, there are no reports of EST being used both for the placing of 
the catheter and later during CEA. The repetition of EST would be particularly interesting in cases 
where at first a CEA was functioning well but later would fail to yield adequate analgesia; hence, 
one would suspect that the catheter tip no longer lies within the epidural space. 
Finally, continuous spinal anaesthesia (CSA) has received increasing attention [Denny and 
Selander 1998] with the introduction of small calibre spinal catheters (so-called microcatheters). 
CSA enables incremental doses of the local anaesthetic to be injected, thus providing for spinal 
anaesthesia of an adequate degree and duration that is suitable also for prolonged surgery. After 
CSA, the spinal catheter can be utilized to administer continuous spinal postoperative analgesia 
(CSPA). Spinal catheters have been used for CSPA with good results mainly in orthopaedic patients 
[Denny and Selander 1998].  
 
The clinical studies carried out here focused on measures to deliver effective, well-tolerated, and 
good-quality continuous neuraxial postoperative analgesia:  
a) the α2-adrenergic agonists adrenaline and clonidine that were used as adjuvants to CEA 
administered at a lumbar level after arterial bypass surgery of the legs or total knee arthroplasty;  
b) the confirmation of the epidural catheter position by EST in conjunction with CEA in patients 
scheduled for major abdominal surgery or thoracotomy; and  
c) CSPA administered through a microcatheter after arterial bypass surgery of the lower 
extremities.  
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Review of the Literature 
Need for effective postoperative analgesia 
Postoperative pain treatment should be an integral component of the routine surgical and 
anaesthetic management not only for humanitarian reasons [Cousins et al. 2004] but also because it 
can help to reduce morbidity and complications as well as accelerate rehabilitation [Kehlet 1999]. 
For example, resolute pulmonary and physical rehabilitation are crucial to prevent potential 
pulmonary complications especially after thoracotomy and major abdominal procedures. 
Rehabilitation, however, may be hindered by inadequate postoperative analgesia [Crews and 
Bridenbaugh 1995]. In another reference, severe pain after total knee arthroplasty (TKA) can delay 
the early commencement of physiotherapy which can have negative effects on rehabilitation being 
successful [Capdevila et al. 1999]. Furthermore, surgery stimulates a complex stress response 
characterised by endocrine and metabolic changes in addition to inflammatory and 
immunosuppressive consequences. This stress reaction can increase morbidity and mortality from 
myocardial ischaemia, thromboembolic events, and infections. Good postoperative analgesia is an 
important avenue to attenuate the surgical stress response [Kehlet and Dahl 2003]. This appears 
particularly vital in patients whose organ functions are already impaired preoperatively. For 
example, patients with generalized arteriosclerosis presenting for artery repair surgery often are 
elderly and have various co-existing diseases.  
Furthermore, the association between tissue damage of surgery, severity of acute postoperative 
pain and persistent postoperative pain is well known [Perkins and Kehlet 2000]. Tissue damage 
caused by surgery can initiate pathophysiological processes in the peripheral and central nervous 
system that may lead to chronicity [Cousins et al. 2000]. For instance, persistent pain after 
arthroplasty is a known problem; in a prospective observational study more than 18% of patients 
reported moderate to severe pain at six months and 13% at one year following TKA [Brander et al. 
2003].   
Regardless of the many advances in pain management, acute postoperative pain remains an 
important cause of considerable suffering [Dolin et al. 2002; Apfelbaum et al. 2003]. The overall 
mean (95% CI) incidence of moderate-severe and severe postoperative pain was almost 30% (26%–
33%) and 11% (8%–13%), respectively, in pooled data from about 20 000 patients treated with 
intramuscular opioid, patient controlled analgesia (PCA), or epidural analgesia [Dolin et al. 2002].  
Spinal and epidural anaesthesia (neuraxial anaesthesia) 
Spinal and epidural anaesthesia refer to the administration of a local anaesthetic into the intrathecal 
and epidural space, respectively. The origin of these central or neuraxial anaesthesia techniques 
began more than a century ago. Since then, neuraxial anaesthesia has undergone many 
developmental changes both in drugs and equipment, such as, the popularization of the loss-of-
resistance (LOR) technique to identify the epidural space [Dogliotti 1933] and the continuous 
intrathecal technique via an indwelling catheter [Tuohy 1944]. 
Today, spinal and epidural anaesthesia are used for a wide variety of surgical procedures 
including orthopaedic and vascular surgery of the lower limbs, and gynaecological and obstetrical 
surgery. Debate continues as to whether regional anaesthesia results in less postoperative morbidity 
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and mortality than does general anaesthesia (GA). A meta-analysis of over 140 trials where surgery 
was performed either under GA alone or under neuraxial block with or without GA indicated that 
central neuraxial blockade reduced cardiac, pulmonary, and thromboembolic morbidity and 
mortality by 30%–50% in patients who had undergone lower-body surgery [Rodgers et al. 2000]. A 
Cochrane Systematic Review of GA versus neuraxial anaesthesia in adults for hip surgery showed a 
reduced risk of deep vein thrombosis and one month mortality in favour of neuraxial anaesthesia 
[Urwin et al. 2000]. Other randomized studies including many hundreds of patients each, found 
little subgroup advantage or no benefit in favour of neuraxial anaesthesia with regard to mortality or 
major complications [Bode et al. 1996; Park et al. 2001; Norris et al. 2001; Rigg et al. 2002; Peyton 
et al. 2003]. Various possible explanations for this discrepancy include the wide variety of possible 
techniques (which regional technique should be compared to which combination of general 
anaesthetic drugs), the use of heterogeneous patient populations, and the including of older studies 
in the comparison (because overall improvement in perioperative care has favourably affected 
prognosis and would thus affect the data) [Wildsmith 2003; De Leon-Casasola 2003]. In any case, 
Wildsmith feels that postoperative analgesia is of better quality when regional anaesthesia is 
employed [Wildsmith 2003].  
From single-dose to continuous neuraxial anaesthesia and 
analgesia 
Earlier, only short-acting local anaesthetics such as cocaine and procaine were available and 
therefore the duration of the single-dose neuraxial anaesthesia was insufficient for longer lasting 
procedures. This situation was improved by the arrival of longer acting local anaesthetics, e.g., 
bupivacaine. Other attempts to provide prolonged neuraxial anaesthesia included the addition of 
other drugs to the local anaesthetic (e.g., vasoconstrictors [Pitkin 1940]), the development of 
sustained release preparations (e.g., [Paavola et al. 1998]), and, last but not least, repeated or 
continuous intrathecal and epidural administration of drugs (regarding the latter, see Table 1).  
 
Table 1. Main stages in development of continuous neuraxial anaesthesia (modified from [Brill et al. 2003]). 
Year Comment 
1907 Concept to top-up spinal anaesthesia through spinal needle left in place after puncture by Dean  
1931 Introduction of continuous (fractional doses) epidural (caudal) block in obstetrics by Aburel  
1940 CSA by use of indwelling malleable needle and special split mattress by Lemmon  
1942 Epidural (caudal) block by catheter in obstetrics independently described by Manalan and by Edwards and 
Hingson  
1944 CSA by means of urethral catheter by Tuohy  
1990 Introduction of microcatheters for CSA by Hurley and Lambert  
CSA=Continuous spinal anaesthesia.  
 
The concept of continuous spinal anaesthesia (CSA) was first considered in 1907 with the 
intention to administer top-ups of local anaesthetic during surgery through the spinal needle left in 
place after lumbar puncture. This technique carried considerable risks since the needle could easily 
cause direct damage to the surrounding tissues. The first continuous epidural (caudal) anaesthesia 
using a catheter was portrayed in 1942 (Table 1). In 1944, the first catheter technique for CSA was 
described with a No. 4 urethral catheter inserted through a 15G needle [Tuohy 1944]. However, 
fears that CSA would result in high incidences of postdural puncture headache (PDPH), as well as 
reports of low success rates [Dripps 1950] led to its decline. The use of CSA was further reduced by 
the expansion of the epidural catheter technique [Bromage 1954]. In 1990, the CSA technique 
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experienced a renaissance with the introduction of thinner catheters called ‘microcatheters’. [Hurley 
and Lambert 1990] (Table 1). With such fine catheters (as thin as 32G), it was believed that the 
incidence of PDPH would be lessened. However, the enthusiasm over CSA administered through 
microcatheters was dampened by reports of cauda equina syndrome [Rigler et al. 1991]. In the 
meanwhile, based on further clinical and experimental evaluation, it was reasonably argued that the 
problem with the cauda equina syndrome was not related per se to the microcatheter technique but 
rather to the direct neurotoxic effect of large doses of hyperbaric local anaesthetic [Rigler and 
Drasner 1991; Denny and Selander 1998].  
Despite the setbacks and technical problems experienced, continuous neuraxial anaesthesia 
remains a useful tool for selected patients [Denny and Selander 1998; Rodgers et al. 2000; 
Michaloudis et al. 2000; Groeben 2006]. In addition, the catheter which is already in place can be 
utilized for epidural or spinal analgesia after surgery.  
Continuous spinal anaesthesia (CSA) 
Tuohy (Table 1) wrote with respect to the benefits of prolonged access to the intrathecal space 
[Tuohy 1944]: “The advantage of the serial or fractional doses should be axiomatic since the 
anesthetic agent may be added as it is needed and the necessity of administering a large or relatively 
large amount at one time, the so-called single dose method, is eliminated.” This implies that CSA 
offers two major advantages over single-dose spinal anaesthesia (SSA). Firstly, it is possible to 
attain anaesthesia of an adequate level and suitable (prolonged, if necessary) duration. Secondly, by 
titrating the local anaesthetic, it facilitates the regulation of the spread of the block and thus reduces 
the risk of abrupt cardiovascular depression compared with SSA.  
CSA offered haemodynamic stability [Morrison et al. 1991; Labaille et al. 1992; Mahisekar et 
al. 1991] and improved haemodynamic control as compared to SSA and epidural anaesthesia 
[Sutter et al. 1989; Klimscha et al. 1993; Favarel-Garrigues et al. 1996; Casati et al. 1996; Holst et 
al. 1997; Maurer et al. 2003]. But, in contrast, there are other reports with less consistent 
differences regarding haemodynamic parameters when comparing CSA to SSA [Pitkänen et al. 
1992a; Bevacqua 1993; Lundorff et al. 1999; Sabaté et al. 1994].  
An intrathecal catheter allows the provision of regional anaesthesia and analgesia in situations 
when SSA and epidural anaesthesia would not generally be recommended (aortic stenosis, 
hypertrophic cardiomyopathy) or when the identification of the epidural space might be difficult 
(severe obesity, extremity of age) [Michaloudis et al. 2000]. Many anaesthetists prefer CSA for 
surgery of long duration and in elderly patients with a complex medical history [Denny and 
Selander 1998]. Prolonged surgery and co-existing diseases such as hypertension, ischaemic heart 
disease, diabetes mellitus, and chronic obstructive pulmonary disease are features often encountered 
in patients scheduled for peripheral arterial bypass surgery [Ellis et al. 1995].  
The CSA technique must be very meticulously carried out because, “while spinal anaesthesia is 
not necessarily more dangerous than epidural anaesthesia, the subarachnoid space is markedly less 
forgiving of mistakes than the epidural space” [Bevacqua 2003].  
Continuous neuraxial analgesia 
In the anaesthetic literature, the abbreviation CSA is commonly used to describe the continuous 
administration of spinal anaesthesia for the duration of surgery. Some authors, however, use this 
abbreviation for continuous spinal analgesia given after surgery. In order to better distinguish 
between these two entities here, the acronym CSPA is employed when referring to continuous 
spinal postoperative analgesia. The shortened form CEA indicates continuous epidural analgesia 
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given postoperatively. The abbreviations LEA and TEA differentiate between lumbar and thoracic 
epidural analgesia, respectively.  
The epidural and spinal routes for the administration of drugs are often used for the treatment 
of acute perioperative as well as chronic pain. This is in analogy to epidural and spinal anaesthesia 
where local anaesthetics are given close to the spinal cord and nerve roots with the aim to apply 
minimal yet effective drug doses with only limited side-effects.  
Continuous spinal postoperative analgesia (CSPA) 
The history of postoperative pain relief utilizing CSPA began more than half a century ago [Ansbro 
et al. 1952]. Following the introduction of thinner catheters two decades ago, the technique has 
been revived [Hurley and Lambert 1990; Denny and Selander 1998].  
CSPA has been used with good results particularly in orthopaedic patients [Standl et al. 1995a; 
Niemi et al. 1996; Bachmann et al. 1997; Möllmann et al. 1999; Maurer et al. 2003; Gurlit et al. 
2004]. In some studies, however, complicating factors of recurring motor blockade have surfaced 
during CSPA with bupivacaine [Niemi et al. 1996; Bachmann et al. 1997]. For this reason, CSPA 
with ropivacaine might be advantageous with regard to the incidence and degree of motor blockade 
[McClure 1996].   
There are also promising reports describing patient-controlled CSPA after orthopaedic surgery 
[Rundshagen et al. 1997; Vercauteren et al. 1998; Rundshagen et al. 1998]. 
Continuous epidural analgesia (CEA) 
CEA has been used for postoperative analgesia for many decades. The Australian and New Zealand 
College of Anaesthetists and Faculty of Pain Medicine lately described CEA as follows [ANZCA 
2005, page 110]: “Epidural analgesia … has become a widely used technique for the management 
of acute pain in adults and children, particularly after surgery and sometimes trauma, and in 
parturients.” The universal efficacy of CEA as a pain relieving method is well documented. In a 
meta-analysis [Block et al. 2003], epidural analgesia provided better postoperative analgesia when 
compared with parenteral opioids. CEA when compared to parenteral opioids given either 
intravenously by PCA or intramuscularly resulted in a significant lower incidence of moderate-
severe pain (21% versus 36% and 67%, respectively) and severe pain (8% versus 10% and 29%, 
respectively) [Dolin et al. 2002]. Superior pain relief was noted with CEA in contrast to other 
measures after intra-abdominal aortic, gastric, biliary, or colon operations [Park et al. 2001], after 
major abdominal surgery in high-risk patients [Rigg et al. 2002], after intra-abdominal surgery 
[Werawatganon and Charuluxanun 2005], after coronary artery bypass surgery [Liu et al. 2004], 
and after TKA [Choi et al. 2003; Farag et al. 2005].  
Whether CEA as a single intervention has beneficial effects on morbidity and mortality remains 
a matter of debate, probably because the complex perioperative care has not been adjusted 
sufficiently in past analyses [Kehlet and Dahl 2003]. Moreover, it is difficult to summarize the 
available data related to its efficacy because CEA is not a standardized entity but can be supplied by 
various pharmacological drugs, given at different levels of the epidural space, and for a wide range 
of procedures [De Leon-Casasola 2003]. Nevertheless, there is abundant data suggesting that CEA 
can reduce morbidity with respect to several organ systems (Table 2). For example, CEA supported 
early rehabilitation and functional outcome after TKA and reduced the incidence of graft occlusion 
after peripheral vascular surgery (Table 2).
Table 2. Potential benefits of continuous epidural analgesia on postoperative morbidity and mortality. 
Organ system or outcome 
parameter 
Potential beneficial effect 
Myocardium Reduction in postoperative myocardial infarction with TEA [Beattie et al. 2001; Beattie 
et al. 2003] 
Reduced cardiac dysrhythmias [Liu et al. 2004; Guay 2006a] 
Respiratory system Improved oxygenation of blood and reduction in pulmonary complications, e.g., 
pulmonary infections [Ballantyne et al. 1998] 
Reduced respiratory failure [Rigg et al. 2002] and pulmonary complications [Liu et al. 
2004] 
Earlier extubation [Liu et al. 2004; Groeben 2006; Guay 2006a] 
Gastrointestinal system Reduced gastrointestinal paralysis compared with opioid-based analgesia after abdominal 
surgery [Jørgensen et al. 2000] 
Stress response Reduction of sympathoadrenergic stress response after thoracotomy [Salomäki et al. 
1993] and TKA [Adams et al. 2002] 
Rehabilitation Better knee flexion, faster ambulation, and shorter hospital stay after TKA [Singelyn et 
al. 1998] 
Improved early rehabilitation after TKA [Farag et al. 2005] 
Graft performance after 
vascular surgery 
Lower incidence of re-operation for inadequate tissue perfusion [Christopherson et al. 
1993] 
Decreased risk of arterial thrombotic complications [Rosenfeld et al. 1993] 
Reduced incidence of graft occlusion and improved graft blood flow [Perler et al. 1995]  
TEA=Thoracic epidural analgesia. TKA=total knee arthroplasty. 
 
CEA is a safe and practical method for pain treatment in the usual postsurgical ward setting 
with few complications provided that patients are under strict regular surveillance by trained staff 
[Salomäki et al. 1996; Rygnestad et al. 1997; Wheatley et al. 2001]. This also applies to patient-
controlled epidural analgesia which has become increasingly popular over the past years 
[Vercauteren et al. 1995; Liu et al. 1998; Silvasti and Pitkänen 2001; Standl et al. 2003].  
As an interim summary, CEA with a low-dose combination of a local anaesthetic and opioid is 
recommended for pain treatment in major surgery [Kehlet and Dahl 2003]. Nevertheless, it cannot 
always provide sufficient pain relief: The incidence of moderate to severe pain was 21% and that of 
severe pain reached almost 8% in a recent review [Dolin et al. 2002]. One concept to improve 
neuraxial analgesia is to use additional compound drugs or ‘adjuvants’. 
Adjuvants 
Adjuvants in neuraxial analgesia – general aspects 
Adjuvants are substances which by themselves possess low potency or in higher doses display 
undesirable side-effects but allow for a reduction of doses of other co-administered active 
compounds. The combination thus may allow for reduced doses of each drug accompanied with 
fewer dose-related side-effects. The component drugs from various pharmacological classes can 
produce a desired effect by additive or even synergistic (‘supra-additive’) mechanisms. This idea 
has important implications in any therapeutic area in which additive and synergistic combinations 
may be utilized to develop the potency, efficacy, or therapeutic window associated with the 
treatment regimen. Synergy-enabled decreases in the dose may prove advantageous in clinical pain 
management as, for example, in chronic, opioid-resistant pain [Coombs et al. 1986]. However, 
when investigating adjuvants for potential benefits, one must keep in mind that combining several 
drugs might unexpectedly result in antagonistic (‘sub-additive’) interactions. 
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In the 1970s, the discovery of opioid receptors in the brain [Goldstein et al. 1971; Pert and 
Snyder 1973] and spinal cord tissues [LaMotte et al. 1976] offered new possibilities for central 
neuraxial analgesia [Yaksh and Rudy 1976]. Originally, it was thought that opioids applied through 
the neuraxis might be as effective as when given systematically albeit in lower doses and thus 
having a reduced risk of respiratory depression. Therefore, much was expected from this new mode 
of pain treatment which is virtually devoid of effects on the motor function or sensory modalities. 
However, over the years it was concluded that neuraxial opioids are not free from meaningful side-
effects (e.g., respiratory depression) and alone do not solve all problems of pain. 
Nowadays, local anaesthetics and opioids are often combined for central neuraxial analgesia 
with plenty of basic pharmacologic and clinical evidence that pain management can be improved in 
this manner [Breivik 1992; Solomon and Gebhart 1994; Vercauteren and Meert 1997; Walker et al. 
2002]. Opioids play such an integral role in most regional anaesthetic techniques that many authors 
regard them as routine rather than adjuvant compounds. 
With the epidural and intrathecal route of administration, achieving effective analgesia may be 
restricted due to adverse effects. Local anaesthetics may cause hypotension and weakness of the 
legs [Block et al. 2003; Bachmann et al. 1997], while opioids may result in nausea, itching, and the 
depressed breathing [Breivik 1992; Block et al. 2003]. The frequency and degree of such side-
effects are for the most part dose-dependent.   
α2-Adrenergic agonists – general aspects 
Important adjuvants for regional anaesthesia include the α2-adrenergic agonists adrenaline 
(epinephrine) and clonidine. The interest in α2-adrenoceptor agonists has increased during the last 
two decades. In 1992, Gordh noted [Gordh 1992] that such compounds may offer a new approach to 
neuraxial analgesia with a decreased risk of respiratory depression [Penon et al. 1991].  
Agonists of α2-adrenergic receptors provide dose-dependent pain relief by an opioid-
independent mechanism [Yaksh and Reddy 1981]. They produce antinociception by stimulating the 
postsynaptic α2-adrenergic receptors in the dorsal horn of the spinal cord. This mimics the effect of 
noradrenaline which is released from descending inhibitory pathways in the central nervous system. 
Thus, a decreased activity of second-order neurons and wide dynamic range neurons in the dorsal 
horn occurs [Reddy et al. 1980; Yaksh and Reddy 1981; Collins et al. 1984; Murata et al. 1989] 
which, in turn, attenuates the input from peripheral nociceptive Aδ and C fibres. The analgesic 
effect transmitted through α2-adrenergic receptors is reversed by the α-receptor antagonist 
phentolamine, although it remains unaffected by the β-receptor antagonist propranolol or the opioid 
antagonist naloxone [Reddy et al. 1980; Yaksh and Reddy 1981]. 
Functional interactions between µ-opioid receptors and α2-adrenergic receptors have been 
described. They share a common signalling system mediated through inhibitory G-proteins whose 
activation results in increased potassium conductance and cell membrane hyperpolarisation in the 
Locus coeruleus of the brain stem [Aghajanian and Wang 1987]. Synergistic effects between µ-
opioid receptors and α2-adrenergic receptors are found at the spinal level in vivo [Meert and De 
Kock 1994; Stone et al. 1997]. Interactions between α2-adrenergic agonist and local anaesthetics 
have also been proposed, e.g., the potentiation of the effect of lidocaine by clonidine [Gaumann et 
al. 1992; Hao et al. 2001]. 
Adrenaline 
For more than a century, adrenaline (epinephrine) has been utilized as an adjuvant in regional 
anaesthesia [Weber 1904]. This has been done in order to reduce plasma concentrations of co-
administered drugs and to enhance their anaesthetic action [Covino and Wildsmith 1998; Burm et 
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al. 1986]. This action is primarily due to adrenaline’s vasoconstrictive properties: By decreasing the 
local blood flow the absorption of co-administered local anaesthetics and opioids is delayed which, 
in turn, intensifies and prolongs the actions of the compounds [Covino and Wildsmith 1998; 
Bernards and Kopacz 1999]. A second possible mechanism of (peripheral) block improvement by 
adrenaline is described in a proposed two-compartment model, having an outer compartment 
(including epineurial tissue) and an inner ‘effector’ compartment (including endoneurium and nerve 
fibres) [Sinnott et al. 2003]: The observation that similar intraneural lidocaine contents produced 
varying degrees of analgesia (with intensified analgesia in the presence of adrenaline) might be 
because adrenaline facilitated the uptake of the local anaesthetic into the effector compartment 
[Sinnott et al. 2003]. The antinociceptive capability of neuraxial adrenaline communicated through 
α2-adrenoreceptors [Reddy et al. 1980; Collins et al. 1984] was seen in humans both for intrathecal 
[Priddle and Andros 1950] and lumbar epidural administration [Curatolo et al. 1997]. 
Adrenaline 200–500 µg (single-dose) added to different spinal local anaesthetics gave varying 
results with respect to the prolongation of the block depending upon the dose of adrenaline and the 
local anaesthetic used. The addition, for example, of adrenaline 200 µg to an intrathecal dose of 7.5 
mg bupivacaine prolonged sensory modalities, duration of motor blockade, and the time to void by 
about 30–50 min [Moore et al. 1998]. Thus, adrenaline may extend surgical anaesthesia for 
ambulatory surgery but, at the same time, delay the time until patients achieve discharge criteria 
[Moore et al. 1998].  
Adrenaline added to epidural bupivacaine accelerated the onset of analgesia [Eisenach et al. 
1987] and amplified the degree of the motor block during labour [Eisenach et al. 1987; Laishley 
and Morgan 1988]. It increases the duration of epidural anaesthesia with shorter-acting local 
anaesthetics but not with longer-acting agents such as bupivacaine [Kopacz et al. 2001]. When 
added to epidural lidocaine or bupivacaine, adrenaline decreased the peak plasma concentrations of 
the local anaesthetics [Burm et al. 1986; Kopacz et al. 2001]. It is assumed that adrenaline can 
delay the absorption and enhance the anaesthetic and analgesic action of local anaesthetics and 
opioids in the epidural space [Covino and Wildsmith 1998; Niemi and Breivik 1998]. 
In a series of clinical studies, adrenaline in dosages of about 10–20 µg/h produced several 
beneficial effects when added to TEA, including improved pain relief [Niemi and Breivik 1998; 
Sakaguchi et al. 2000; Niemi and Breivik 2002], reduced opioid requirement [Baron et al. 1996], 
and lowered opioid plasma concentrations [Baron et al. 1996; Niemi and Breivik 1998]. These were 
accompanied with either a reduced [Niemi and Breivik 1998; Niemi and Breivik 2002] or an 
unaffected [Baron et al. 1996; Sakaguchi et al. 2000] incidence of side-effects. In a dose-response 
finding study of TEA after major thoracic or upper abdominal surgery, the minimally effective 
concentration of adrenaline required to maintain relief of dynamic pain was 1.5 µg/ml (18 µg/h on 
average) when added to bupivacaine 1 mg/ml and fentanyl 2 µg/ml [Niemi and Breivik 2003]. 
Adrenaline seems to be a useful adjuvant for thoracic CEA, but its value in lumbar CEA 
remains contradictory [Curatolo 2002]. The addition of adrenaline 0.5 µg/ml [Cohen et al. 1998] 
and 1.0 µg/ml [Cohen et al. 1992] to an epidural combination of bupivacaine and fentanyl after 
caesarean section gave no benefit except for a slightly lower infusion rate in the group with the 
adrenaline concentration of 1.0 µg/ml [Cohen et al. 1992]. In these two studies, adrenaline doses 
were about 8 µg/h (with additionally patient controlled boluses, maximum 9 µg/h) [Cohen et al. 
1998], and 14 µg/h (with on demand epidural boluses, maximum 5 µg/h) [Cohen et al. 1992]. The 
discrepancy between TEA and LEA could be due to anatomical differences, such as the distance 
between the site of administration and the site of the α2-adrenergic receptors in the spinal dorsal 
horn level [Curatolo et al. 1997]. By increasing the dosage of adrenaline added to LEA it might be 
possible to increase the availability of adrenaline at the spinal cord level and thereby to improve the 
epidural analgesia transmitted through α2-adrenergic receptors. 
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Clonidine 
Following local anaesthetics and opioids, clonidine is the most studied drug used for human 
neuraxial analgesia [Maze and Tranquilli 1991]. It has been implemented as an adjuvant drug in 
miscellaneous regional anaesthesia techniques [Eisenach et al. 1996], including CEA [Armand et 
al. 1998]. Clonidine is moderately lipid soluble and easily penetrates the blood-brain barrier leading 
to spinal and supraspinal receptor binding. Although the systemic administration of clonidine can 
provide analgesia, its primary site of antinociceptive action appears to be at the spinal level 
[Bernard et al. 1995; Eisenach et al. 1996; Eisenach et al. 1998]. Similar to epidural adrenaline (see 
above), epidural clonidine produces segmental hypoalgesia to painful stimuli [Curatolo et al. 1997]. 
In a dose-response study, epidural clonidine 3–10 µg/kg (maximum 900 µg) yielded analgesia 
in a dose-dependent manner after abdominal surgery or TKA and with 700–900 µg it produced 
complete analgesia lasting 4–6 h. Such high doses, however, caused the typical, dose-dependent 
side-effects related to clonidine, i.e., hypotension, bradycardia, and sedation [Eisenach et al. 1989]. 
With regard to CEA, clonidine alone achieved adequate pain relief at infusion rates of 100–150 
µg/h [De Kock et al. 1997], but, again, with the typical side-effects related to high doses of 
clonidine.  
Given by the spinal or epidural route, clonidine as an adjunct to local anaesthetics usually 
prolongs the effect of the latter [Racle et al. 1987; Eisenach et al. 1996]. Interestingly, clonidine by 
mouth prolonged lidocaine spinal anaesthesia [Liu et al. 1995]. Intravenous clonidine delivered 
effective postoperative analgesia, for example, following correction of scoliosis [Bernard et al. 
1995]. Clonidine 50 µg/h along with levobupivacaine (7.5 mg/h) gave superior CEA than did either 
drug individually after hip replacement [Milligan et al. 2000]. On the other hand, uncertainty exists 
as to whether clonidine can prolong the effect of epidural or spinal administered opioids [Walker et 
al. 2002]. Nevertheless, some investigations showed a synergistic pain relief, e.g. when combining 
clonidine with morphine [Spaulding et al. 1979; Petit et al. 1989] or sufentanil [Vercauteren et al. 
1990]. Regarding the latter example, epidural bolus administration of sufentanil 25 µg with 
clonidine 1 µg/kg offered superior analgesia after caesarean section as compared to sufentanil 50 µg 
alone. This benefit, however, was achieved at the cost of hypotension [Vercauteren et al. 1990]. 
With respect to continuous neuraxial analgesia, the combination of clonidine and morphine as an 
epidural infusion enhanced analgesia following major abdominal surgery [Motsch et al. 1990]. 
Similar to this, the addition of clonidine in dosages of maximum 37.5 µg/h [Vercauteren et al. 
1994] and 0.03 µg/kg/h [Delaunay et al. 1993] reduced the requirements of epidural sufentanil after 
caesarean section and fentanyl following abdominal surgery, respectively.  
Only a limited number of studies have attempted to exploit the possible benefits of clonidine 
when added to a CEA of an opioid together with a local anaesthetic [Mogensen et al. 1992; Paech 
et al. 1997]. TEA was improved by giving clonidine 18.75 µg/h together with bupivacaine (5 mg/h) 
and morphine (0.1 mg/h) after hysterectomy [Mogensen et al. 1992], or by administering clonidine 
20 µg/h along with bupivacaine (6.25 mg/h) and fentanyl (10 µg/h) after abdominal gynaecological 
surgery [Paech et al. 1997]. However, these clonidine regimens were associated with hypotension 
and bradycardia. Although generally well tolerated by the patients, these untoward effects have 
been considered problematic in the postoperative setting. 
In an effort to determine the most beneficial combinations of bupivacaine, fentanyl, and 
clonidine for TEA [Curatolo et al. 2000] and LEA [Sveticic et al. 2004], several drug mixtures were 
identified as being ‘optimal’ (Table 3 and Table 4), referring to such combinations which provide 
adequate pain relief with minimal side-effects. The authors, however, highlighted that their results 
(Table 3 and Table 4) were not conclusive ones but instead point towards combinations worthy of 
being investigated further in future CEA studies.  
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It remains unknown as to whether epidural clonidine in reduced amounts, e.g., <15 µg/h, may 
still contribute to the efficacy of a CEA consisting of a mixture of low-dose local anaesthetic and 
opioid without causing any significant degree of hypotension, bradycardia, and sedation. 
 
Table 3. Results from a search for optimal combinations of bupivacaine, fentanyl, and clonidine for TEA after 
major abdominal surgery (data from [Curatolo et al. 2000]). 
 Combination 1 Combination 2 Combination 3 
Bupivacaine (mg/h) 9 8 13 
Fentanyl (µg/h) 21 30 25 
Clonidine (µg/h) 5 0 0 
Infusion rate (ml/h) 7 9 9 
Data are doses of component drugs or infusion rates as indicated. From a longer list of investigated drug mixtures, 
Combinations 1–3 were identified by the authors [Curatolo et al. 2000] as ‘optimal’, referring to combinations 
providing adequate pain relief with minimal side-effects. TEA=Continuous epidural analgesia at thoracic level.  
 
 
Table 4. Results from a search for optimal combinations of bupivacaine, fentanyl, and clonidine for LEA after 
knee or hip surgery (data from [Sveticic et al. 2004]). 
 Combination 1 Combination 2 Combination 3 Combination 4 
Bupivacaine (mg/ml) 1.0 0.9 0.6 0.5 
Fentanyl (µg/ml) 1.4 3.0 2.5 2.4 
Clonidine (µg/ml)] 0.5 0.3 0.8 1.0 
Data are concentrations of component drugs. From a longer list of investigated drug mixtures, Combinations 1–4 were 
identified by the authors [Sveticic et al. 2004] as ‘optimal’, referring to combinations providing adequate pain relief 
with minimal side-effects. LEA=Continuous epidural analgesia at lumbar level. Initial infusion rate 7 ml/h, increased 
by 2 ml/h to a maximum of 15 ml/h; additionally, nurse administered 5-ml boluses (lockout time 60 min) for 
breakthrough pain.  
 
Other adjuvants 
The list of possible adjuvants to neuraxial analgesia is expanding as the understanding of the 
complex pain transmission and modulation at the spinal cord level and in the brain become more 
clear [Gordh 1992; Walker et al. 2002; Buckenmaier and Bleckner 2005]: Apart from α2-adrenergic 
agonists, many other substances have been tested in clinical regional anaesthesia, e.g., ketamine, 
magnesium, neostigmine, midazolam, and droperidol. Ketamine, an N-methyl-D-aspartate receptor 
antagonist, may improve pain relief and reduce overall opioid requirements when added to an 
epidural opioid with or without a local anaesthetic [Subramaniam et al. 2004]. On the other hand, a 
study in rats suggested that the additive or synergistic antinociceptive effect of the adjuvant 
ketamine might not be generalizable to all opioids [Hoffmann et al. 2003]. Magnesium can express 
antinociceptive action through the blockade of N-methyl-D-aspartate receptors [Kroin et al. 2000; 
Buvanendran et al. 2002]. Neostigmine, by augmenting the muscarinic cholinergic activity at spinal 
level, may reduce postoperative analgesic requirements [Liu et al. 1999; Almeida et al. 2003]. 
Whatever the potential benefits of such neuraxial adjuvant drugs, one must keep in mind possible 
side-effects, for example, nausea with neostigmine [Almeida et al. 2003] and psychomimetic 
actions with ketamine [Kathirvel et al. 2000], as well as safety concerns [Hodgson et al. 1999; 
Eisenach and Yaksh 2003; Yaksh and Allen 2004].  
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In addition to adrenaline, other drugs with vasoconstrictive actions have been studied as 
adjuncts to neuraxial anaesthesia, e.g., the selective α1-agonist phenylephrine which acts on spinal 
cord and dural blood flow without causing spinal ischaemia [Kozody et al. 1984]. The use of 
phenylephrine, however, has not gained popularity because it increased the frequency of transient 
radicular symptoms when added to spinal tetracaine [Sakura et al. 1997]. 
Safety considerations and compatibility of drug mixtures 
Before applying an adjuvant, possible risks related to its use should be considered, e.g., 
neurotoxicity. Furthermore, chemical and physical compatibility of the various compounds must be 
assessed, as should the stability of the infusions over periods of time.  
Adrenaline and clonidine 
Adrenaline possesses a strong vasoconstrictive potential and therefore one may question whether its 
administration through the neuraxis could induce ischaemic spinal cord injury. Indeed, in rats, 
adrenaline worsened spinal cord injury when added to intrathecal lidocaine 50 mg/ml [Hashimoto et 
al. 2001], as it did when given with tetracaine 10–20 mg/ml in rabbits [Oka et al. 2001]. However, 
it is uncertain as to whether these findings can be extrapolated to humans. Possibly the observed 
adverse effect may be due secondarily to a decreased systemic uptake of, and protracted exposure to 
lidocaine and tetracaine, rather than ischaemic side-effects because adrenaline alone in similar 
doses did not provoke neurotoxicity [Hashimoto et al. 2001; Oka et al. 2001]. In a review, it was 
reasoned that the data from animal studies and from experience gathered in humans over a century 
suggest that adrenaline is indeed a safe adjunct in routine neuraxial anaesthesia [Neal 2003].  
Neuraxial clonidine is considered to be free from neurotoxic effects [Hodgson et al. 1999], 
even after prolonged intrathecal infusion [Gordh et al. 1986].  
Compatibility and stability of drug mixtures 
Various mixtures of local anaesthetics, opioids, and adjuvant drugs have been found compatible and 
stable for weeks [Christie et al. 1992; Wulf et al. 1994; Oster Svedberg et al. 2002]. Adrenaline is 
prone to oxidation when exposed to light and therefore sodium metabisulphite and disodium edetate 
are often added as preservatives to adrenaline preparations. With these preservatives, adrenaline 
remained stable for up to 20 days at 3 or 23 °C when added to bupivacaine hydrochloride and 
fentanyl citrate [Dawson et al. 1992]. 
Side-effects and complications related to neuraxial 
anaesthesia and analgesia 
General aspects 
Side-effects can be regarded as indicators for the safety (hypotension, respiratory depression) and 
the tolerability (motor weakness, nausea, itching, etc.) of the neuraxial techniques. Side-effects may 
limit the provision of effective postoperative analgesia and have been recently quantified in 
anaesthetic practice with special attention given to respiratory depression, hypotension, sedation, 
postoperative nausea and vomiting (PONV), pruritus, motor block, and urinary retention after 
parenteral opioid and epidural analgesia (Table 5 and Table 6) [Block et al. 2003; Cashman and 
Dolin 2004; Dolin and Cashman 2005].  
In a multicenter prospective survey including more than 40 000 spinal and 35 000 epidural 
anaesthetics, serious events such as cardiac arrest, severe neurological injury, respiratory failure, 
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and seizures were reported in 1:1 250 and 1:5 000 patients, respectively [Auroy et al. 2002]. 
Neurological sequelae after neuraxial anaesthesia is not always related to the anaesthetic technique 
itself but may arise de novo; additionally, conditions such as diabetes mellitus and previously 
unrecognized neurological disorders may be associated with new perioperative neurological 
findings [Hebl et al. 2006a; Hebl et al. 2006b]. 
Possible side-effects and complications related to postoperative neuraxial analgesia must be 
taken into account when planning the treatment strategies and counterbalanced with possible 
problems seen with other forms of acute postoperative pain therapy. The patients should have 
adequately educated, dedicated, and vigilant personnel [Rawal and Berggren 1994; Salomäki et al. 
1996]. Awareness, immediate diagnosis, and appropriate treatment of whatever inadvertent event 
that may occur are the foundation for the safe provision of neuraxial techniques. 
 
Table 5. Incidence rates for hypotension, PONV, pruritus, and motor blockade when comparing CEA (local 
anaesthetic with or without opioid) with parenteral opioids (PCA and intramuscular opioids) for 
postoperative analgesia based upon a recent meta-analysis of 100 RCTs performed in adults [Block et al. 
2003]. 
 CEA Parenteral opioids Comment 
Hypotension 8–14 2–14 Hypotension more frequent with TEA compared to 
LEA 
PONV 26–42 25–72 Significant difference for LEA (42%) versus 
parenteral opioids (72%); however, if CEA with 
opioid alone, incidence rate even 45%–80%  
Pruritus 2 0 If LEA with opioid alone, incidence rate even 38% 
Numbness and motor 
blockade 
1–2 0–1  
Data are incidence rates (%). PONV=Postoperative nausea and vomiting. CEA=Continuous epidural analgesia. 
PCA=Patient controlled analgesia with intravenous opioid. RCT=Randomized controlled trial. TEA and LEA=CEA 
given at thoracic or lumbar level, respectively.      
 
Respiratory depression 
The risk of respiratory depression from epidural analgesia utilizing an opioid is dose-dependent and 
occurs at a frequency of 0.1–1.2% [Stenseth et al. 1985; Ready et al. 1991; Scott et al. 1996; 
Cashman and Dolin 2004]. This incidence does not differ from that seen with systemic opioids 
[Mulroy 1996; Cashman and Dolin 2004]. The incidence of respiratory depression seems to have 
decreased during the period 1980-1999 [Cashman and Dolin 2004]. CEA utilizing fentanyl in 
dosages of 10–20 µg/h apparently rarely causes respiratory depression [Breivik 1992], while at 
dosages of 100–125 µg/h severe respiratory insufficiency can occur [Weightman 1991].   
Several conditions may place patients at a greater risk of respiratory depression such as 
increased age, sleep apnoea, and chronic lung conditions. Respiratory depression from lipophilic 
opioids such as fentanyl may occur within 2 h of a bolus dose whereas in the case of a hydrophilic 
opioid as morphine, 6–12 h (or even more) may elapse before this might be manifested. This is 
because of the slow rostral migration within the cerebrospinal fluid (CSF) to the brain stem. Thus, a 
risk of delayed respiratory depression might be expected at least with higher bolus doses of 
morphine [Bailey et al. 1993].  
The respiratory rate alone is not always a reliable predictor of looming respiratory depression 
but the degree of sedation should be monitored as well [Bailey et al. 1993; Mulroy 1996]. If the 
respiratory rate is <10/min or somnolence occurs the following measures should be taken: an 
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attempt to arouse the patient, reduction or interruption of the infusion, as well as the consultation of 
an anaesthetist. Severe respiratory insufficiency should immediately prompt: offering supplemental 
oxygen, ventilation with mask (or even endotracheal intubation), and administration of an opioid 
antagonist, e.g., naloxone 0.1 mg i.v. (to be repeated, if required) [Salomäki et al. 1996].   
 
Table 6. Incidences of adverse effects registered during acute postoperative pain management with CEA, PCA, 
and intramuscular opioids based upon a recent review of the literature including 165 publications 
[Cashman and Dolin 2004; Dolin and Cashman 2005]. 
 CEA PCA Opioid i.m. All together 
Respiratory depressiona     
Respiratory rate 1.1 
(0.6–1.9) 
1.2 
(0.7–1.9) 
0.8 
(0.2–2.5) 
1.1 
(0.7–1.7) 
SpO2 15 
(5.6–35) 
12 
(5.6–22) 
37* 
(23–46) 
17 
(10–27) 
Naloxone 0.1* 
(0.1–0.2) 
1.9 
(1.9–2.0) 
1.4 
(0.1–13) 
0.3 
(0.1–1.3) 
Hypotensionb 5.5* 
(3.2–9.3) 
0.7* 
(0.2–2.4) 
3.6 
(2.0–6.4) 
4.7 
(2.8–7.7) 
Nausea     
Females only  39 
(26–54) 
53 
(37–63) 
58 
(27–73) 
53 
(45–61) 
Females and males 19 
(14–25) 
32* 
(27–38) 
17 
(6.6–37) 
25 
(19–32) 
Vomiting     
Females only 30 
(24–37) 
21 
(14–31) 
49 
(36–63) 
34 
(25–44) 
Females and males 16 
(13–21) 
21 
(17–25) 
22 
(17–28) 
20 
(18–23) 
Sedation     
Mild 14* 
(14–15) 
57 
(54–59) 
54 
(48–59) 
24 
(23–25) 
Excessive 1.2* 
(0.9–1.4) 
5.3 
(4.6–6.4) 
5.2 
(4.1–6.4) 
2.6 
(2.3–2.8) 
Pruritus 16 
(13–20) 
14 
(11–18) 
3.4* 
(1.6–6.9) 
15 
(12–18) 
Urinary retention 29* 
(22–38) 
13 
(6.6–25) 
15 
(9.3–23.8) 
23 
(17–30) 
Data are mean (95% CI) incidence rates (%); numbers >10% were rounded. CEA=Continuous epidural analgesia. 
PCA=Patient controlled analgesia (intravenous). SpO2=Oxygen saturation measured by pulse oximetry.  
*Influence of analgesic technique statistically significant.  
aRespiratory depression as indicated by respiratory rate, SpO2 lower than predetermined value, or by the need for the 
opioid-antagonist naloxone.  
bHypotension as indicated by arterial pressure below predetermined level, or by any other definition.  
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Motor blockade 
When pronounced, numbness and motor blockade of the lower extremities from continuous 
neuraxial analgesia may delay the ever important start of physiotherapy. Motor blockade is the side-
effect most often attributable to CEA when compared to opioids given parenterally; an incidence of 
1%–3% has been reported depending on whether CEA was given at a lumbar or thoracic level and 
whether the infusion included an opioid in addition to the local anaesthetic or not [Liu et al. 1998; 
Wheatley et al. 2001; Block et al. 2003]. 
Recurrence of motor blockade during CSPA became a problem with 1–2 mg/h bupivacaine 
infused after orthopaedic surgery [Niemi et al. 1996; Bachmann et al. 1997]. Replacing bupivacaine 
by ropivacaine in CSPA may prove to be advantageous with regard to the incidence and degree of 
motor blockade because of ropivacaine’s potential for a better sensory-motor differential block 
(similar sensory, but less pronounced motor block with ropivacaine as compared to bupivacaine) 
[Rosenberg and Heinonen 1983; Brockway et al. 1991; Zaric et al. 1996; McClure 1996; Brodner et 
al. 1999]. 
In case of disturbing motor blockade during CEA or CSPA, the local anaesthetic dose 
administered should be reduced or even temporarily stopped. Physicians and nurses should always 
be aware that a reoccurring or deepening motor block of the lower extremities during continuous 
neuraxial analgesia may be an early indicator of epidural haematoma [Horlocker and Wedel 1998].  
Postdural puncture headache (PDPH) 
PDPH may occur after a deliberate or accidental (which may even be unrecognized) breach of the 
dura mater and it generally presents itself within the first two days after puncture [Turnbull and 
Shepherd 2003]. Most patients with PDPH complain of a fronto-occipital headache that manifests 
itself on standing but eases on lying supine. The incidence of PDPH might well be related to the 
needle size and type (higher incidences with cutting wide bore needles as compared to thin needles 
with a pencil-point design) [Turnbull and Shepherd 2003]. The rate of PDPH has been connected to 
the degree of loss of CSF which again is related the size of the needle [Holst et al. 1998]. In case of 
PDPH, the patient should be reassured about the benign nature of the headache which resolves 
spontaneously in the majority of cases. Conservative measures to treat PDPH include bed rest, 
hydration, paracetamol, non-steroidal anti-inflammatory drugs (NSAIDs), and caffeine [Turnbull 
and Shepherd 2003]. An epidural blood patch is indicated if conservative management remains 
ineffective and PDPH is severe or may extend the duration of hospital stay [Turnbull and Shepherd 
2003].   
Since the first catheter technique for CSA was described [Tuohy 1944], there were concerns 
that CSA would present high incidences of PDPH. Such contention has been fuelled, for example, 
by a report showing an overall PDPH incidence of 78% in a population of 18 volunteers (18–30 
years; enrolled in a neuroendocrinological study in which CSF samples were drawn through a 
spinal catheter) [Gosch et al. 2005]. This high PDPH incidence, however, is in contrast to other 
studies [Denny et al. 1987; Mahisekar et al. 1991]. For instance, a single case of PDPH was noted 
in 117 surgical patients in whom a 20G catheter was placed through an 18G needle [Denny et al. 
1987]. In a survey with more than 3 200 patients, the frequency of PDPH was similar for SSA, 
CSA, and combined spinal-epidural anaesthesia (0.9%, 1.5%, and 1.7%, respectively) [Puolakka et 
al. 2000a]. The initial reports regarding 32G catheters showed an incidence of 4% [Hurley and 
Lambert 1990] with complete absence of PDPH in elderly patients [Silvanto et al. 1992; Pitkänen et 
al. 1992b].  
23 
In addition to the thickness of the needle and catheter, one further explanation for the variation 
in the incidences of PDPH reported may be the timing of catheter removal. In the above mentioned 
report with a PDPH incidence of 78%, the catheters were removed 4 h after puncture [Gosch et al. 
2005]. It has been postulated that an inflammatory reaction in the dura mater and the arachnoid 
surrounding the puncture hole produces oedema to such a degree that the site becomes sealed soon 
after removal of the catheter [Denny et al. 1987]. However, with early catheter removal (after 
surgery) the inflammatory reaction might not have sufficiently developed and thus the sealing 
process is impeded permitting a prolonged loss of the CSF into the epidural space. 
Neurological complications 
Persistent neurological injury associated with neuraxial anaesthesia is fortunately rare. In an 
analysis based on patient insurance claims in Finland, it was estimated that serious complications 
occur in about 1:22 000 of spinal and 1:19 000 of epidural anaesthesias [Aromaa et al. 1997]. In all, 
the risk of neurological damage related to the placement of an epidural catheter or infusion is low 
[Auroy et al. 1997; Auroy et al. 2002]. A recent retrospective study of severe neurological 
complications after central neuraxial blockades for the period 1990–1999 produced the following 
results [Moen et al. 2004]. Approximately 1 260 000 spinal blocks and 450 000 epidural blocks 
were carried out, which included 200 000 epidural blocks for the relief of labour pain. The 
complications numbered 127 and included spinal haematoma (n=33), cauda equina syndrome 
(n=32), meningitis (n=29), epidural abscess (n=13), and miscellaneous problems (n=20). Permanent 
neurological damage was observed in 85 patients (1:20 000). The incidence of complications 
ranged from 1:20 000 to 1:30 000 for spinal blockade in all patient groups. As a result of obstetrical 
epidural blockade, the incidence was 1:25 000 while in the remaining epidural anaesthetics the 
incidence was 1:3 600 [Moen et al. 2004]. In that particular study, complications occurred 
significantly more often with epidural blockade than after spinal anaesthesia which is opposite to 
earlier observations [Aromaa et al. 1997; Auroy et al. 1997; Auroy et al. 2002]. Furthermore, the 
data suggests that obstetric patients carry a significantly lower incidence of complications while 
osteoporosis might be a previously neglected risk factor [Moen et al. 2004].  
Radiculopathy following spinal or epidural anaesthesia is connected with paraesthesia or pain 
experienced at the time of needle insertion or drug injection [Auroy et al. 1997; Horlocker et al. 
1997b]. If pain were to occur during the injection, one should immediately stop the injection and 
withdraw the needle.  
Epidural haematoma 
Instrumentation during neuraxial anaesthesia is connected to the risk of vascular trauma within the 
spinal canal and epidural haematoma formation. Although rare, it is a potentially hazardous 
complication with compression of neural tissues in the spinal canal and permanent neurological 
sequelae. The incidence of epidural haematoma is estimated at <1:220 000 after spinal and 
<1:150 000 after epidural anaesthesia techniques [Tryba 1993]. Spinal haematoma after obstetric 
epidural blockade carried the incidence of 1:200 000, dwarfing the incidence of 1:3 600 described 
in female subjects who had undergone TKA [Moen et al. 2004]. A review article covering epidural 
haematoma cases from 1906 to 1994 disclosed that spinal anaesthesia was associated with 15 and 
epidural anaesthesia with 46 haematomas [Vandermeulen et al. 1994]. In 68% of instances, 
haemostatic abnormalities were present, while 25% of them were associated with either difficult or 
bloody catheter insertion [Vandermeulen et al. 1994]. In 15 of 32 patients with an epidural catheter, 
the haematoma manifested itself soon after catheter removal [Vandermeulen et al. 1994]. Therefore, 
this complication must always be kept in mind during the maintenance and after removing the 
catheter.   
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The typical signs of an epidural haematoma are acute back pain, bowel incontinence, urinary 
bladder dysfunction, in addition to motor and sensory deficits of the legs. Often the patients who 
have already recovered from spinal or epidural anaesthesia begin to experience motor and sensory 
blockade. Back pain may be severe, radiate to the legs, and begin before the development of 
neurological signs and symptoms. A low level of suspicion, prompt confirmation of the diagnosis 
(preferentially with magnetic resonance imaging), and swift (<6–8 h) surgical evacuation (if 
necessary) are required to prevent permanent neurological sequelae.  
Several reviews and national guidelines are available to help the clinician in estimating the 
patient’s coagulation status and antithrombotic medication [Gogarten et al. 2003; Horlocker et al. 
2003; Bombeli and Spahn 2004; Niemi and Lassila 2004]. For instance, intraoperative 
heparinization in vascular surgery during arterial clamping should be delayed for at least 1 h after 
neuraxial instrumentation.   
The occurrence of symptomatic haematomas following intraoperative anticoagulation in 
vascular surgery patients with epidural or spinal catheters seems to be rare assuming proper patient 
selection, an atraumatic technique, and appropriate monitoring of anticoagulant activity [Rao and 
El-Etr 1981; Raggi et al. 1987; Ellis et al. 1995].   
Infections 
Epidural abscess is a rare complication which, however, can lead to permanent neurological injury. 
Abscesses have been reported both after epidural anaesthesia [Ngan Kee et al. 1992] and chronic 
epidural catheterization [Du Pen et al. 1990]. The signs and symptoms of an epidural abscess may 
be similar to those of epidural haematoma; however, the patient may in addition develop a fever. 
Diagnosis is best with magnetic resonance imaging and treatment choices span from intravenous 
antibiotics to percutaneous drainage and surgical intervention. 
Meningitis associated with central neuraxial techniques is rare with the majority of cases due to 
bacterial nosocomial infection. Meningitis may present itself with headache, nausea, vomiting, 
photophobia, nuchal rigidity, and fever. Diagnosis is by CSF examination and culturing, and by 
treatment with antibiotics.  
Up to 5% of skin puncture sites may become inflamed when an epidural catheter is left in situ 
for >24 h. While this may not indicate an infection in itself, cellulites or purulent discharge from the 
puncture site should prompt catheter removal, initiation of an empiric antibiotic, and culturing of 
the catheter tip.  
There appear to be no reports of serious infections with CSA [Horlocker et al. 1997a]. 
Occasionally, microbiological testing was positive for Staphylococcus epidermidis when culturing 
spinal catheter tips 24 h after catheter placement [Lindgren et al. 1995; Standl et al. 1995b]. These 
findings probably represented only contamination from normal skin flora. There are no prospective 
trials looking into the incidence of infective complications with spinal catheters. In most studies 
postoperatively, spinal catheters were left in situ for a maximum of 1–2 days.  
The use of continuous neuraxial anaesthesia and analgesia requires meticulous aseptic 
technique during insertion and maintenance of the catheter which as well includes the use of a 
bacterial filter.  
Technical problems related to neuraxial techniques 
Rates of technical failure have been reported to be comparable for SSA, CSA, and combined spinal-
epidural anaesthesia (1.0%, 1.5%, 1.0%, respectively) [Puolakka et al. 2000a]. CEA can fail 
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because of technical problems in as much as 6%–25% of cases, with many centres reporting failure 
rates of 10%–20% [Block et al. 2003]. A recent audit at the Meilahti Hospital, Helsinki University 
Hospital – where Studies I and V were carried out – revealed CEA related technical problems to 
range from 10%–15% in gastroenterological, thoracic, vascular, and urologic surgery in the years 
1997–2004 (E. Nilsson, personal communication, 2007).  
The success rates for inserting intrathecal catheters were 90% with a 24G epidural catheter 
through a 19G Tuohy needle and a 28G microcatheter through a 22G spinal needle. On the other 
hand, success rate was 63% using the catheter-over-the-needle technique, i.e., a 22G spinal catheter 
over a 27G spinal needle advanced through an epidurally placed 18G Crawford needle [Puolakka et 
al. 2000b]. The failure rate for inserting the very fine 32G catheters was encountered in some 25% 
of all instances [Silvanto et al. 1992; Pitkänen et al. 1992b; Guinard et al. 1993]. The various 
difficulties experienced with microcatheters were in passing the catheter through the needle, 
kinking, breakage, failure to aspirate, dislodgment of the adapter, and leakage through the adapter 
[Silvanto et al. 1992; Pitkänen et al. 1992b; Niemi et al. 1994; Puolakka et al. 2000b]. It should be 
mentioned that catheters with removable stylets have been developed to prevent kinking during the 
insertion.  
Confirmation of epidural catheter position 
In clinical routine, the identification of the epidural space by the LOR technique and the placement 
of an epidural catheter depend mainly on the experience acquired by the anaesthetist but without 
any visual control of the catheter position. The improper positioning of thoracic epidural catheters 
is believed to occur in 10%–15% of the patients [Rigg et al. 2002]. If the tip of the catheter is not 
properly situated in the epidural space, the analgesia will be most likely inadequate.   
Failure to correctly identify the epidural space can be because of insufficient experience of the 
practitioner and more so due to anatomical anomalies. A ‘pseudo-LOR’ may transpire after a short 
distance of needle passage within the interspinous ligament because of cavity formation [Bromage 
1954; Rissanen 1960; Davidson 1966; Sharrock 1979]. Such degenerative cavities are especially 
frequent in the elderly [Rissanen 1960] and may easily take up 10–20 ml of fluid or air used during 
the puncture [Sharrock 1979]. Similar degenerative changes in the ligamentum flavum have been 
described [Wildi et al. 2004; Asamoto et al. 2005]. A misleading LOR might also develop if the 
needle deviates from its intended course and enters the paravertebral muscles [Bonica 1956] or even 
the pleural cavity (e.g., [Patermann et al. 2005]).  
After identifying the epidural space and placing the catheter, the catheter may change its 
position with the patient’s movements [Hamilton et al. 1997]. The catheter can move 1–2 cm 
inward and outward during CEA, independent of whether the catheter has been tunnelled or sutured 
to the skin [Chadwick et al. 2003]. The catheter tip may even completely slip out of the epidural 
space. The incidence of premature catheter dislodgement is about 6%–12% [Scott et al. 1995; Dolin 
et al. 2002]. In addition, there are reports of delayed subarachnoid migrations, i.e., dura perforations 
by the catheter [Robson and Brodsky 1977]. Subarachnoid migration bears the risk of total spinal 
anaesthesia [Skowronski and Rigg 1981]. 
Therefore, in the interest of the patient, routine confirmation of the catheter’s position must be 
carried out before CEA is initiated. The classical method to assure the correct position is to give a 
test dose of a local anaesthetic and after several minutes to check for signs of sensory blockade 
[Bromage 1954]. However, this test dose concept is not free of problems (see below) and thus 
various alternative methods have been suggested (e.g., [Lewis et al. 1992; Tsui et al. 1998; Ghia et 
al. 2001; Lechner et al. 2003; Willschke et al. 2006]). One of these alternatives is the epidural 
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stimulation test (EST) [Tsui et al. 1998]. In the following, EST will be described in more detail and 
compared (Table 7) to epidurography as well as to the epidural test dose.  
 
Table 7. Advantages and disadvantages of three techniques used to confirm the position of epidural catheters. 
 Test dose EST Epidurography 
Established in clinical routine Yes No No, but proven beneficial in 
various circumstances 
Indirect / direct method Indirect, subjective Indirect, objective 
muscle twitching 
Direct visualization of catheter 
Possible to perform bed-side Yes Yes No (Yes only with mobile X-
ray equipment) 
Special epidural catheter Not required Required Not required 
Exposure to radiation No No Yes 
Adverse effects Risk of total spinal 
anaesthesia 
Not reported Allergic reactions possible but 
serious adverse effects very 
rare 
Results available Sensory block may take 
10–20 min to develop 
Immediately during 
performance 
Processing of X-ray film 
Expenditures Minor Moderate High 
Test dose=Epidural test dose of local anaesthetic and assessment of sensory blockade. EST=Epidural stimulation test, 
i.e., the assessment of motor response elicited by electrical neurostimulation. Epidurography=Epidural contrast medium 
and X-ray of the spine.  
 
Epidural test dose 
As mentioned above, the classical method of assuring the correct catheter position is to administer a 
test dose of a local anaesthetic [Bromage 1954], e.g., 3 ml lidocaine 20 mg/ml with adrenaline 5 
µg/ml [Poblete et al. 1999; Guay 2006b], and then to observe for signs of sensory blockade. 
However, sensory changes after such a test dose are often weak and barely assessable, particularly 
in the very young and elderly patient, as well as in the disorientated or heavily premedicated 
patient. Therefore, testing sensory blockade includes subjectivity of both the patient and the 
assessor (Table 7). As the sensory block may require 10–20 min to develop, it may create problems 
in the operation room because of time constraints. Still, it is an easy method requiring only basic 
equipment (Table 7). There is, however, the risk of test dose being inadvertently administered 
intrathecally which could result in sudden cardiovascular depression and total spinal anaesthesia. 
Therefore, corresponding patient monitoring and emergency equipment should always be on hand.  
Epidural stimulation test (EST) 
Tsui and colleagues proposed a potentially simple, fast, reliable, and safe method to assure the 
epidural catheter position [Tsui et al. 1998; Tsui et al. 1999b]: They applied electrical 
neurostimulation (1 Hz, 0.2 sec, maximum 16 mA) through the catheter and judged the position of 
the latter to be epidurally if muscle response in the torso or in the extremities would be elicited at a 
current of 1–10 mA. Instead, the catheter tip is considered to be outside the spinal canal when the 
motor response occurs at a current >10 mA or remains absent despite maximum stimulation, while 
twitching at <1 mA is a warning sign of an inadvertent subarachnoid catheter placement [Tsui et al. 
1998].  
This test has been named the epidural stimulation test (EST), and ‘Tsui test’ by the inventor. 
The advantages attributed to EST are that it is easily and quickly performed at the patient’s bedside 
with only moderate costs. In addition, because it produces a visible muscle twitching it should 
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prove more objective and reliable than an epidural test dose (Table 7). Thus, EST may prove 
beneficial especially in patients with limited verbal communication [Tsui et al. 1998]. Nevertheless, 
it remains an indirect method for the confirmation of epidural catheter placement (Table 7).  
The EST technique was originally performed one or two days postoperatively in patients with a 
metal coil reinforced epidural catheter [Tsui et al. 1998]. The purpose of the metal coil within the 
lumen of the catheter is to aid in conducting the electrical impulse along the entire length of the 
catheter.  
Technical preconditions for EST include that the epidural catheter is equipped with a metal 
wire [Tsui et al. 1998; Tamai et al. 2005; Tsui and Sze 2005] which goes along with somewhat 
increased costs compared to a standard epidural catheter (Table 7). Besides, the neurostimulator 
must have certain requirements regarding the amplitude and duration of impulse; otherwise, it may 
be difficult to compare results gained by different study groups [Charghi et al. 2007]. The use of 
EST is contraindicated in individuals with pacemakers and other implanted electrical devices [Tsui 
et al. 1998]. 
EST has been subject of several reports [Tsui et al. 1999c; Tsui et al. 1999a; Tsui et al. 2000; 
Goobie et al. 2003; Tsui et al. 2004a; De Medicis et al. 2005; Tsui et al. 2007; Charghi et al. 2007], 
but as yet has not been widely accepted in clinical routine. So far, it seems not to have been 
employed repeatedly during postoperative CEA. The repetition of EST might be of particular 
interest when an initially well working CEA begins to fail to produce adequate analgesia and where 
the catheter tip is suspected of no longer being within the epidural space. 
Epidurography 
Epidurography was introduced as an X-ray diagnostic method in 1926 [Sicard and Forestier 1926]. 
By administering 3–15 ml of contrast medium through the epidural catheter followed by a 
radiogram of the spinal column, it is possible to visualize the position of the catheter (e.g., [Wulf et 
al. 1993; Du Pen et al. 1996; Collier 1998]). Thus, epidurography is a direct method to confirm the 
position of the catheter as compared to the indirect epidural test dose and EST (Table 7). Excluding 
patients with thyrotoxicosis or iodine-allergy and with the use of water-soluble iodinated contrast 
media, epidurography is a safe procedure [Collier 1998]. Adverse reactions to the epidural 
administration of contrast medium are generally rare and transient in nature. These include local 
pressure sensation, feeling of warmth, metallic taste on accidental intravascular application, and 
allergic reactions. Although the latter are mostly mild to moderate skin or respiratory reactions, 
severe allergic reactions such as hypotension, tachycardia or bradycardia, and seizures have been 
reported.  
Attempts to correlate the spread of contrast solution in the epidurogram with the extent of 
nerve block met with only limited success. In other words, adequate epidural analgesia with 
bilateral blockade does not correlate with bilateral and symmetrical diffusion of contrast into the 
epidural space [Collier 1998; Hogan 1999; Motamed et al. 2006]. Nonetheless, epidurography in 
most instances reveals whether or not the catheter lies in the epidural space. It has become a 
valuable tool in pain management [Wulf et al. 1993] and it has even been considered for routine 
quality assurance regarding CEA [Seeling et al. 1995]. However, it has not gained further 
popularity probably because there is a need for radiology staff, bulky equipment, and exposure to 
radiation of the patient (Table 7).  
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Assessment of pain intensity 
Pain intensity should be also assessed during significant movement or activity rather than only at 
rest. These include measurement during flexion and extension of an operated joint or deep 
breathing and/or coughing following thoracotomy or abdominal surgery. 
Various validated scores are available for the assessment of pain intensity. It is commonly 
estimated by either a categorical (verbal or numerical) rating scale or a so-called visual analogous 
scale (VAS), e.g., a 10 cm long scale (linear or triangle shaped) indicating the range from ‘no pain’ 
to ‘worst pain imaginable’ [Sriwatanakul et al. 1983a; Sriwatanakul et al. 1983b]. Often patients, 
especially the elderly with visual defects may present difficulties with the standard 10-cm scale. 
Enlarging the VAS scale to 50 cm has addressed this problem [Tigerstedt and Tammisto 1988]. 
The Prince Henry Hospital pain score (PHH-score) [Pybus and Torda 1982] and its modified 
form [Torda et al. 1995] have been devised specifically for the evaluation of pain after abdominal 
or thoracic surgery by examining the effect of analgesia on deep breathing and coughing. The 
modified PHH-score is defined as follows [Torda et al. 1995]: PHH-score 3=pain at rest, PHH-
score 2=pain during deep breathing, PHH-score 1=pain on coughing, PHH-score 0=no pain on 
coughing. 
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Aims of the Study 
The primary hypothesis of this study was to determine whether the efficacy and quality of 
continuous neuraxial postoperative analgesia might be improved by the use of adjuvant drugs and 
by technical means. The following issues were of specific interest: 
 
1. To investigate whether adrenaline in concentrations of 2 µg/ml (Study I) and 4 µg/ml (Study II) 
added to low-dose ropivacaine-fentanyl mixtures improves the continuous epidural analgesia 
given at a lumbar level after arterial bypass surgery (Study I) and total knee arthroplasty (Study 
II), respectively. 
2. To assess whether low-dose clonidine (6–14 µg/h) enhances lumbar continuous epidural 
analgesia when added to a low-dose infusion of ropivacaine and fentanyl following total knee 
arthroplasty (Study III). 
3. To study the feasibility of a continuous spinal anaesthesia technique utilizing a microcatheter in 
patients undergoing arterial bypass surgery of the lower extremities (Study IV), and to examine 
the analgesic efficacy of a continuous spinal infusion of ropivacaine alone (maximum 2 mg/h) 
or one of ropivacaine together with morphine (maximum 1 mg/h and 8 µg/h, respectively) after 
arterial bypass surgery on the legs with special attention paid to motor blockade (Study IV). 
4. To evaluate the feasibility of the epidural stimulation test to determine the position of the 
epidural catheter at the time of its placement and then its position during continuous epidural 
analgesia in patients undergoing major abdominal surgery or thoracotomy (Study V).  
5. To register and analyze possible technical problems which may occur during continuous 
epidural and spinal anaesthesia and analgesia (Studies I–V). 
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Patients and Methods 
Study designs and randomization 
The study protocols were approved by the Ethics Committee of Helsinki University Hospital (I–V) 
and by the National Agency for Medicines (I–IV). Written informed consent was obtained from all 
study patients before the procedures.  
Table 8 presents an overview of the types of surgery, anaesthesia, postoperative analgesia, 
drugs for postoperative analgesia, and other methodological aspects of Studies I–V. 
 
Table 8. Outline of methods applied in Studies I–V. 
 Study I Study II Study III Study IV Study V 
Surgery Lower extremity 
arterial bypass 
TKA TKA Lower extremity 
arterial bypass 
Major abdominal or 
thoracotomy 
Anaesthesia SSA SSA SSA CSA GA 
Neuraxial analgesia 
technique 
CEA CEA CEA CSPA CEA 
Drugs used for CEA 
and CSPA 
Ropivacaine 
+ Fentanyl 
± Adrenaline 
Ropivacaine 
+ Fentanyl 
± Adrenaline 
Ropivacaine 
+ Fentanyl 
± Clonidine 
Ropivacaine 
± Morphine 
Ropivacaine 
+ Fentanyl 
Other aspects ABPI and plasma 
concentrations 
   EST and epiduro-
graphy 
TKA=Total knee arthroplasty. SSA=Single-dose spinal anaesthesia. CSA=Continuous spinal anaesthesia. GA=General 
anaesthesia. CEA=Continuous epidural analgesia. CSPA=Continuous spinal postoperative analgesia. ABPI=Ankle-
brachial blood pressure index. EST=Epidural stimulation test. Symbol ‘±’ stands for: Study group with, control group 
without this drug. 
 
In the randomized, controlled trials (RCT), patients were randomized to either a study or a 
control group regarding the drugs given for CEA (I–III) and CSPA (IV) with the patients in the 
control groups receiving an active comparator medication. In Study IV, before randomization to 
either of the CSPA groups, each patient underwent intraoperative observation regarding the CSA 
technique. In the diagnostic, prospective Study V, no randomization was performed and all patients 
were treated according to the same trial protocol which included a standardized CEA.  
Patients as well as physicians and nurses who were involved in the investigation were blinded 
as to the allocation of the study groups throughout the course of trials (I–IV). Block randomization 
together with the closed envelope method were used. The randomization envelopes were prepared 
by colleagues who did not take part in the study. The randomization codes were opened by an 
anaesthesia nurse at the time of the patient’s arrival in the postanaesthesia care unit (PACU) after 
the operation. The nurse preparing the study drugs did not take any further part in the treatment or 
follow-up of that particular patient. After preparing the study drugs, the nurse placed the 
randomization code back into the envelope which again was sealed and kept among the patient’s 
charts. 
Patients, surgical procedures, and exclusion criteria 
Patients enrolled to Study I and IV underwent arterial bypass surgery of the lower extremities. 
Patients in Studies II and III were scheduled for primary, unilateral TKA. Study V consisted of 
patients having major abdominal surgery (gastrointestinal or urologic) or thoracotomy.  
Exclusion criteria included contraindications to the insertion of an epidural or spinal catheter 
such as haemostatic abnormalities and/or therapeutic anticoagulation, and infection at the puncture 
site. Patients on an adenosine diphosphate receptor antagonist or an inhibitor of the platelet receptor 
GPIIb/IIIa were excluded unless that drug had been discontinued well in advance as recommended 
[Niemi and Lassila 2004]. The other exclusion criteria are listed in Table 9.  
 
Table 9. Exclusion criteria in addition to contraindications to insertion of an epidural or spinal catheter (see text) 
for Studies I–V. 
Excluded if  Study I Study II Study III Study IV Study V 
Age (years) <18 <18 and >85 <18 and >85 <18 <18 
ASA class >IV ≥IV ≥IV >IV >IV 
Renal insufficiency Yes, if combined 
with renal replace-
ment therapy 
Yes Yes Yes, if combined 
with renal replace-
ment therapy 
Yes 
Known allergy to 
NSAIDs 
NA Yes Yes NA No 
Heart insufficiency 
(NYHA classes III 
and IV) 
No Yes Yes No No 
BMI>36 kg/m2 No Yes Yes No Yes 
Iodide allergy NA NA NA NA Yes 
Pacemaker or other 
implanted electrical 
device 
NA NA NA NA Yes 
ASA class=American Society of Anesthesiologists physical status classification. NSAID=Non-steroidal anti-
inflammatory drug. NA=Not applicable. NYHA=New York Heart Association classification. BMI=Body mass index.  
 
Preoperative considerations and premedication 
Before their operations, the patients received their normal morning medication, with angiotensin-
converting enzyme inhibitors, diuretics, and drugs for diabetes mellitus being withheld. 
Thromboprophylaxis [Gogarten et al. 2003; Niemi and Lassila 2004] was initiated with dalteparin 
5 000 IU s.c. (I, IV, and V) or enoxaparin 40 mg s.c. (II) in the evening before surgery followed by 
a corresponding amount of low-molecular weight heparin (LMWH) s.c. once daily (II and V) or 
dalteparin 2 500–5 000 IU s.c. twice daily as prescribed by the vascular surgeon (I and IV). In 
Study II, instead of LMWH some patients were given fondaparinux 2.5 mg s.c. once daily if the risk 
of deep vein thrombosis was considered high according to the recommendation of the internist. The 
initial dose of fondaparinux was given 6–9 h postoperatively. A variation of the 
thromboprophylaxis regimen was used in Study III consisting of dalteparin 2 500 IU s.c. one hour 
after the administration of the spinal anaesthesia, followed by 2 500 IU s.c. in the evening of that 
day – this was then followed with 5 000 IU s.c. once daily (based on [Hull et al. 2001]). The timing 
of placement and removal of epidural and spinal catheters in relation to LMWH and fondaparinux 
was according to recent guidelines [Gogarten et al. 2003; Niemi and Lassila 2004]. Catheter 
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placement and removal was not undertaken until at least 10 h had elapsed from the last dose of 
LMWH or 20 hours in patients with fondaparinux. Correspondingly, the consecutive LMWH or 
fondaparinux dose was withheld at least for 2 h after removing the catheter. 
Premedication was with diazepam p.o. given 1 h before arriving in the operating theatre (I–V). 
The patients also received i.v. midazolam and fentanyl when needed for the insertion of the catheter 
(I–V), or for sedation and/or pain, e.g., position-related discomfort, during the operation (I–IV). 
Intraoperative monitoring included pulse oximetry, electrocardiogram (ECG), and non-invasive 
arterial blood pressure (II, III, and V). Invasive arterial pressure measurement was used in all 
patients from Studies I and IV and, when clinically indicated, in some patients of Study V. A 
central vein catheter for the measurement of central vein pressure (CVP) was inserted in all patients 
of Study IV, as it was in several patients of Studies I and V. All patients had a urinary catheter with 
hourly urine output being recorded (I–V). 
Anaesthesia and other intraoperative aspects 
Anaesthesia techniques 
Table 10 summarizes details related to the anaesthesia techniques used in Studies I–V. Epidural 
catheters were placed prior to the puncture for spinal anaesthesia (I–III) or GA (V). The LOR 
technique was used to identify the epidural space. Spinal anaesthesia was provided with plain 
bupivacaine 5 mg/ml in Study I and with plain ropivacaine 7.5 mg/ml in Studies II–IV. The spinal 
anaesthesia was carried out with the patient in the lateral decubitus position in Studies I–III after 
which the patient was turned supine. On the other hand, in Study IV, the first dose of local 
anaesthetic was given through the intrathecal catheter only after the patient had been turned to the 
supine position. Epidural top-ups were permitted in Studies I–III in case of an early spinal block 
regression. In Study IV, intrathecally administered top-ups were an integral part of the CSA 
technique (Table 10). During the induction phase of Study IV, titration of the spinal anaesthesia 
with frequent top-ups was allowed with at least 3 min elapsing between two successive doses. The 
aim was to obtain a sensory block up to dermatome T10. The dermatomal spread of spinal 
anaesthesia was determined by testing for loss of cold sensation with an alcohol-soaked cotton swab 
20 min after spinal anaesthesia was made (II and III). The sensory block (hypoaesthesia to cold) 
and motor blockade (modified Bromage scale, Table 13) were tested at 5 min intervals during the 
induction phase of Study IV until the degree of sensory block attained, at least, the level of 
dermatome T10.  
Infusion therapy and haemostasis 
The patients received Ringer’s acetate solution 5–10 ml/kg i.v. before spinal anaesthesia (I–IV). In 
Study IV, this pre-loading was guided by the measurement of CVP (aiming at a CVP of ≥3 mmHg) 
before the first intrathecal dose of ropivacaine was injected. The intraoperative infusion therapy 
regimen consisted of Ringer’s acetate, plasma expander, and transfusion of blood components as 
clinically indicated. The infusion therapy was adjusted according to urine output and blood loss.  
In Studies I and IV, heparin 100 IU/kg i.v. was given 2 min before the artery was clamped. The 
need for additional heparin was evaluated by monitoring of the activated clotting time. Intravenous 
protamine and intra-arterial papaverine were injected at the discretion of the vascular surgeon.  
A thigh tourniquet was applied during TKA (II and III). In Study III, tranexamic acid 
(Caprilon®, Leiras, Finland) 0.5–1.0 g i.v. was used to reduce bleeding when ordered by the 
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surgeon. In Study II, tranexamic acid 0.5 g i.v. was administered before inflation and again a short 
while before the release of the tourniquet.  
 
Table 10. Anaesthesia. 
 Study I Study II Study III Study IV Study V 
Position during 
puncture 
Lat. decub. Lat. decub. Lat. decub. Lat. decub. Lat. decub. or 
sitting 
Level epidural / spinal 
catheter 
L1–2 L2–3 or L3–4 L2–3 or L3–4 L3–4 or L2–3 Thoracic levela 
Catheter type Perifix® or 
FlexTip Plus® 
Portex® Portex® CoSpan®b FlexTip Plus® 
Epidural test dose 4 ml L 1% c. adr. 
10 µg/ml 
Study mixture, 
after surgery 
3 ml R 0.75% NA 3 ml + 3 ml 
L 2% c. adr. 
5 µg/ml 
Level spinal needle 
puncture 
L3–4 L3–4 or L4–5 L3–4 or L4–5 See above NA 
Anaesthesia SSA SSA SSA CSA GA 
Drugs used for spinal 
anaesthesia 
3 ml B 0.5% 3 ml R 0.75% 3–4 ml R 0.75% Initially 1.0 ml 
R 0.75% 
NA 
Top-ups Epidural, L 2% 
c. adr. 5 µg/ml 
Epidural, 
R 0.75% 
Epidural, 
R 0.75% 
Spinal, 0.5 ml 
R 0.75% 
R 0.75% at end 
of surgery 
Lat. decub.=Lateral decubitus position, side to be operated on top. c. adr.=With adrenaline. L=Lidocaine. 
R=Ropivacaine. B=Bupivacaine. NA=Not applicable. SSA=Single-dose spinal anaesthesia. CSA=Continuous spinal 
anaesthesia. GA=General anaesthesia. 
Perifix®=Epidural catheterization set, needle 18G, B. Braun, Germany.  
FlexTip Plus®=Epidural Catheterization Set, needle 17G, catheter 19G, Arrow International Inc., Reading, USA.  
Portex®=Epidural Minipack, needle 18G, Portex Ltd., Hythe, Kent, UK.  
CoSpan®=Set for continuous spinal anaesthesia, Quincke needle 22G, catheter 28G, Kendall, Neustadt, Germany.    
aAt an appropriate thoracic intervertebral interspace with regard to the planned surgical incision. 
bWith Tuohy-Borst® adapter. 
 
Intraoperative phase of Study IV 
After the initial spinal dose of local anaesthetic, arterial pressure, CVP, and heart rate were 
recorded at 3 min intervals for 15 min and then every 5 min for the next 45 min. The sensory block 
and the motor blockade were evaluated every 5 min during the induction phase until the level of 
sensory block was above T10. 
At the end of surgery, the surgeon was questioned at to whether the motor block had been 
satisfactory; and this was graded as: complete motor block – minor movements, manageable – 
movements to a disturbing degree. 
General anaesthesia in Study V 
Anaesthesia was induced intravenously with fentanyl and propofol followed by rocuronium to 
achieve muscle relaxation. Anaesthesia was maintained with sevoflurane in an air-oxygen mixture. 
Increments of intravenous fentanyl and rocuronium where given as needed. Sevoflurane was 
replaced by desflurane in four patients and by a combination of propofol and remifentanil infusions 
in three patients at the discretion of the attending anaesthetist. 
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Postoperative pain management 
Continuous epidural and spinal analgesia 
Table 11 shows some aspects of postoperative pain management including drug combinations and 
infusion rates used for CEA and CSPA. The infusion rates were regulated as needed in a stepwise 
manner, i.e., decreased for hypotension or pronounced motor block and increased for surgical pain. 
In Study IV, in order to prevent accidental overdose, the display of the syringe pump used for 
CSPA was marked with alerting red tapes and a warning text that the infusion speed must not 
exceed 0.4 ml/h. 
In Studies I–III, the postoperative epidural infusion was started when the dermatomal 
hypoaesthesia to cold had dropped to the level of the groin and first the voluntary contractions of 
thigh muscles were noted. In Study IV, the spinal infusion was begun with the first voluntary 
contractions of the thigh muscles. In Study V, the epidural infusion was started after the 
performance of the epidural nerve stimulations EST4 (see below under heading ‘Methods used in 
Study V’ as well as Figure 1). 
 
Table 11. Continuous epidural or spinal postoperative analgesia.  
 Study I Study II Study III Study IV Study V 
CEA or CSPA CEA CEA CEA CSPA CEA 
Drugs used for CEA 
and CSPA 
Group RF: 
R 1 mg/ml  
+ F 2 µg/ml 
Group RFA: 
same as in RF 
+ A 2 µg/ml 
Group RF: 
R 1.8 mg/ml 
+ F 3 µg/ml 
Group RFA: 
same as in RF 
+ A 4 µg/ml 
Group RF: 
R 2 mg/ml 
+ F 5 µg/ml 
Group RFC: 
same as in RF 
+ C 2 µg/ml 
Group R: 
R 2 mg/h 
 
Group RM: 
R 1 mg/h 
+ M 8 µg/h 
All patients: 
R 1.67 mg/ml 
+ F 7.5 µg/ml 
Bolus at beginning of 
CEA or CSPA 
No Yes 
(study infusion) 
Yes 
(study infusion) 
No Noa 
Infusion rate 1 ml/10 kg/h 
(maximum 10 
ml/h), intention 
to keep rate 
constantb 
Initially 5 ml/h, 
later adjusted 3–8 
ml/h 
Initially 5 ml/h, 
later adjusted 3–7 
ml/h 
Initially 0.4 ml/h, 
later adjusted 
0.1–0.4 ml/h 
Initially 5 ml/h, 
later adjusted 3–
10 ml/h 
Top-ups during CEA 
or CSPA 
No Yes 
(study infusion) 
No No Yes 
(study infusion) 
Infusion scheduled Until afternoon 
Day 2 
Until 12:00 
Day 2 
Until 
12:00 Day 1 
For 24 h At least until 
11:00 Day 2 
Follow-up until Afternoon Day 2 12:00 Day 2 12:00 Day 1 48 h after 
catheter 
placement 
Afternoon Day 2 
CEA=Continuous epidural analgesia. CSPA=continuous spinal analgesia. R=Ropivacaine. F=Fentanyl. A=Adrenaline. 
C=Clonidine. M=Morphine. Day 1 and 2=First and second postoperative day, respectively. The adrenaline formula 
added to CEA in Studies I and II contained the preservatives sodium edetate and sodium metabisulphite (Adrenalin®, 
Leiras, Turku, Finland). 
aHowever, 5 ml of ropivacaine 7.5 mg/ml were given as an epidural bolus at the end of surgery.  
bHowever, reduced if pronounced hypotension or motor blockade.  
 
The total amounts of epidurally administered drugs in Studies II–IV were calculated from those 
infusion rates marked on the patient’s chart. The nurses had been instructed to be very diligent 
when recording the epidural infusion forms – kept bed-side – whenever infusion rate changes were 
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made. These data concerning infusion rates and time of infusion rate changes were entered to a 
spreadsheet application programmed by the author for this purpose (spreadsheet based on 
Microsoft® Excel 2002, Microsoft Corporation, Redmond, WA, USA).  
Rescue pain medication  
Table 12 summarizes data pertaining to additional regular pain medication and rescue pain 
medication. The first dose of propacetamol or paracetamol (acetaminophen) was given either 
together with the initiation of the continuous neuraxial infusion or already at the end of surgery (V). 
Furthermore, those patients who had knee replacement began receiving a NSAID in the evening 
following their operation. NSAIDs were considered contraindicated in the vascular surgery patients. 
The first-line rescue pain medication (Table 12) was either a bolus of the epidural infusion in 
Studies II and V or oxycodone given i.v. or i.m. in Studies I and III. If two successive doses failed 
to provide sufficient pain relief, the patients of Study II and V then received oxycodone i.v. or i.m. 
whereas those patients belonging to Studies I and III had an epidural bolus of ropivacaine as a 
second-line rescue drug. In Study IV, only oxycodone i.v. or i.m. was used as rescue medication.  
 
Table 12. Additional and rescue pain medication. 
 Study I Study II Study III Study IV Study V 
Additional regular 
medication 
     
Propacetamola 2 g i.v. Every 8 h for 
24 h, then … 
-- Single-dose, 
then … 
-- -- 
Paracetamolb 1 g i.v. -- Single-dose, 
then … 
-- Every 8 h for 
24 h, then … 
Every 8 h 
until … 
Paracetamol 1 g p.o. … every 8 h … every 8 h … every 8 h … every 8 h … allowed to 
take p.o. every 
8h 
Rofecoxibc 25 mg p.o. -- -- Every 12 h -- -- 
Rofecoxibc 50 mg p.o. -- Every 24 h -- -- -- 
Celecoxibd 200 mg or 
diclofenace 50 mg  
(p.o.)f 
-- Every 12 hf -- -- -- 
NSAID or tramadol 
(i.v. or p.o.) 
-- -- -- -- On demand 
(maximally 3 
times a day) 
Rescue pain medication      
First-line Oxycodoneg i.v. 
or i.m.h 
Bolus of epidural 
infusion 
Oxycodoneg i.v. 
or i.m.h 
Oxycodoneg i.v. 
or i.m.h 
Bolus of epidural 
infusion 
Second-line Epidural bolus of 
ropivacaine  
Oxycodoneg i.v. 
or i.m.h 
Epidural bolus of 
ropivacaine  
-- Oxycodoneg i.v. 
or i.m.h 
aProDafalgan®, Bristol-Myers Squibb.       
bPerfalgan®, Bristol-Myers Squibb.  
cVioxx®, MSD.  
dCelebra®, Pfizer.  
eVoltaren®, Novartis.  
fInstead of rofecoxib after the latter had been withdrawn in September 2004.  
gOxanest®, Leiras.  
hIntravenous application in the postanaesthesia care unit and intramuscular on the ward. 
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Postoperative study parameters 
Each study had its own study-specific follow-up chart. The study parameters and the assessment 
tools applied in each of the studies are shown in Table 13. The length of follow-up for each trial is 
listed in Table 11 while the times of postoperative interviews are displayed in Table 14. Study 
parameters were measured at least at each predetermined interview (Table 14) but additional 
recordings were made during routine nursing, particularly in case of any complaint and problem 
potentially related to postoperative pain treatment. When it came to statistical evaluation, data 
pertaining to blood pressure, heart rate, and respiratory rate were forwarded for analysis as 
measured at the predetermined interview. However, a different data handling was preferred with 
 
Table 13. Study parameters after surgery. 
 Comment 
Study parameter  
Pain intensity Evaluated at rest and during movement (e.g., flexion of knee) on VAS graded from zero (no 
pain) to 10 (worst pain imaginable). VAS was 50 cm long (I, IV, and V) or 10 cm (II, III).  
Additionally, in Study V, pain assessed with modified PHH-score [Torda et al. 1995]: 
PHH-score 3=pain at rest 
PHH-score 2=pain during deep breathing 
PHH-score 1=pain on coughing 
PHH-score 0=no pain on coughing 
Motor blockade Assessed using modified Bromage scale [Bromage 1965]: 
0=no motor blockade  
1=just able to move knees 
2=able to move feet only 
3=unable to move feet or knees 
Vital parameters Blood pressure, heart rate, respiratory rate 
Sedation Evaluated as follows: 
0=patient fully awake 
1=patient tired or snoozes but easily wakes 
2=patient sleeps or is drowsy but easily wakes 
3= patient difficult to wake up 
PONV Assessed as follows:  
0=no nausea or vomiting 
1=nausea 
2=retching or vomiting 
Pruritus Key: 
0=none  
1=slight to moderate  
2=strong  
Final interview  
Overall satisfaction Overall satisfaction with pain management regimen estimated with one or more of the 
following: 
- Four-step verbal rating scale 
- Numerical rating scale from zero (worst) to ten (best) 
- “Would you choose the same kind of pain treatment for similar surgery in  
   the future?” – yes/no/cannot say 
Drowsiness In Study III, at end of study: “Did you feel drowsy to a disturbing extent during the epidural 
study infusion?” (subjective estimate – yes/no/cannot say) 
Prompt sequelae after 
CSA/CSPA 
In Study IV: 48 hours after placement of spinal catheter, to record any possible prompt 
problems or complaints attributable to spinal catheter technique 
VAS=Visual analogue scale. PHH-score=Modified Prince Henry Hospital pain score. PONV=Postoperative nausea and 
vomiting. CSA=Continuous spinal anaesthesia. CSPA=Continuous spinal postoperative analgesia.  
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respect to pain intensity at rest and during movement, satisfaction with pain treatment regimen, 
motor blockade, sedation, pruritus, as well as nausea and vomiting. Here, for each interval between 
two interviews, the highest or ‘worst’ value observed and recorded was passed on to data analysis 
although it may not have been one of the predetermined measurements. 
 
Table 14. Time patterns of study parameter recording (interviews). 
 Time pattern of interviews  
Study I First interview 6 h after start of CEA, next interviews at 09:00 and 14:00 both on Day 1 and 2 
Study II Interviews every hour for first three hours of epidural infusion, then at 18:00 Day 0, thereafter every 
six hours until 12:00 Day 2 
Study III First interview at 18:00 Day 0, thereafter interviews every 6 hours until 12:00 Day 1 
Study IV Interviews 4 and 8 hours after start of CSPA, next interview at 09:00 Day 1, and, finally, later on 
during Day 1 when spinal infusion was stopped 
Study V Patients observed in PACU several hours and until pain intensity was ≤3 on VAS. Interviews at 
09:00 and 14:00 both on Day 1 and 2 
CEA=Continuous epidural analgesia. Day 0=Day of surgery. Day 1 and 2=First and second postoperative day, 
respectively. CSPA=Continuous spinal postoperative analgesia. PACU=Postanaesthesia care unit. VAS=Visual 
analogous scale. 
 
 
Treatment of bradycardia, hypotension, nausea and vomiting, 
and pruritus 
Intraoperatively, glycopyrrolate i.v. or atropine sulphate i.v. were given for bradycardia. If 
hypotension occurred, this was treated by intravenous fluid challenge and, if necessary, with 
intravenous bolus doses of ephedrine. In Study I and IV, the first-line intraoperative vasopressor 
was intravenous phenylephrine while ephedrine i.v. was given if bradycardia accompanied 
hypotension.  
Postoperatively, atropine sulphate i.v. was administered for bradycardia. Intravenous fluid 
challenge and boluses of ephedrine i.v. were given for hypotension (or phenylephrine i.v. in the 
PACU, Studies I and IV).  
PONV was treated as required with a 5-HT3 receptor antagonist i.v. combined, if necessary, 
with metoclopramide i.v. or with droperidol i.v. Pruritus was treated with oral hydroxyzine, as 
needed. 
Study specific methods 
Measurement of plasma drug concentrations (Study I) 
Blood samples were collected into EDTA-tubes 6, 24, and 48 h after the start of the epidural 
infusion. The samples were centrifuged and the plasma stored at –20°C for determination of plasma 
concentrations of ropivacaine and fentanyl using high-performance liquid chromatography.   
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Ankle-brachial blood pressure index (ABPI) (Study I) 
The ankle-brachial blood pressure index (ABPI) was measured preoperatively and in the morning 
of the first postoperative day in order to estimate whether the addition of adrenaline had an 
influence on the blood circulation of the lower extremities.  
Methods used in Study V, including EST and epidurography 
Some methods used in Study V varied from those in Studies I–IV and are, therefore, described in 
detail. Figure 1 gives an overview of the course of Study V including times when the various tests 
and measurements were performed (EST1–6, TD1–2, PinPrick1–2, Epidgr1–2, and measurement of pain 
scores). The epidural bolus of ropivacaine given at the end of surgery (Figure 1) consisted of 5 ml 
of ropivacaine 7.5 mg/ml. Figure 1 also shows when CEA was started in the PACU and when it was 
interrupted in relation to EST6.  
 
Figure 1. Flowchart giving an overview of the various tests and measurements performed during Study V. 
EST=Epidural stimulation test. TD=Epidural test dose of 3 ml lidocaine 20 mg/ml with adrenaline 5 µg/ml. 
PinPrick=Evaluation of dermatomal spread of the sensory blockade with a pin-prick needle. Epidural bolus at end of 
surgery=5 ml of ropivacaine 7.5 mg/ml. Epidgr=Epidurography. CEA=Continuous epidural analgesia. Day 1 and 
2=First and second postoperative day, respectively. Pain scores=Pain intensity rated in the morning and afternoon of 
Day 1 and in the morning of Day 2 utilizing a modified PHH-score (Table 13) followed by evaluation of maximum 
pain intensity on a VAS scale (Table 13).  
 
Catheter placement (Study V) 
After performing the LOR technique with physiological saline, a 19G epidural catheter (FlexTip 
Plus®, Epidural Catheterization Set, Arrow International Inc., Reading, USA) was advanced 4 cm 
beyond the tip of the Tuohy needle. The SnapLock® catheter adapter, a Johans ECG adapter® 
(Arrow International Inc.), a 3-way stop cock, and a bacterial filter were attached to the catheter in 
this order.   
EST (Study V) 
Supervised hands-on training in the EST technique preceded Study V. EST was performed utilizing 
similar equipment and according to the method described by Tsui and colleagues [Tsui et al. 1998]. 
These included the metal coil reinforced epidural catheter FlexTip Plus®, the Johans ECG adapter®, 
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and the nerve stimulator Dakmed model 750 digital® (Dakmed Inc., Buffalo, USA). Briefly, the 
electrical impulse (1 Hz, 0.2 sec) was gradually increased from zero to maximally 16 mA or until 
muscle twitching became observable. The position of the epidural catheter tip was then assessed as 
follows [Tsui et al. 1998]:  
a) within the epidural space, if truncal or lower limb motor response occurs at 1–10 mA; 
b) outside the spinal canal if motor response is first seen at a current >10 mA, or is absent; 
c) intrathecally or directly against a nerve root if a motor response is manifested at <1 mA. Here, a 
polymyotome twitching would indicate an intrathecal position whereas a unilateral, segmental 
response combined with a negative aspiration test for CSF should suggest that the catheter tip 
lies directly on a nerve root (but not intrathecally). 
The current applied at the onset of myotomal activity (motor response threshold) was recorded, 
as was the level at which the patients first felt the electrical stimulation (sensory response 
threshold). In each patient, EST was repeated six times (EST1–6) (Figure 1). The motor response 
was divided to one of the following categories [Goobie et al. 2003]: Category T1–6 (intercostal 
muscle), Category T7–12 (rectus abdominus and external oblique muscle), or Category L1-5 (hip 
flexion). Before EST1, the catheter-adapter assembly was primed with physiological saline 1–2 ml. 
If the electrical circuit during EST was interrupted then the system was flushed with small amounts 
of physiological saline.  
Epidural test dose and pin-prick (Study V) 
After EST1, with the patient remaining in the sitting position or in the lateral decubitus position, the 
first epidural test dose (TD1) was given (Figure 1). The patient was then turned into the supine 
position. Three minutes after TD1, the dermatomal spread of sensory blockade was tested using a 
pin-prick needle (PinPrick1). At 5 minutes from TD1, EST2 was performed, and at 10 minutes, a 
second analogous test dose (TD2) was given (Figure 1). The spread of sensory block was tested 
again (PinPrick2) and EST3 performed 3 and 5 min after EST2, respectively (Figure 1). 
Epidurography (Study V) 
The initial epidurography (Epidgr1, anteroposterior view) was taken on the patient’s arrival in 
PACU, and the second (Epidgr2, anteroposterior and lateral view) was performed at 11:00 on Day 2 
(Figure 1). The contrast media, either 5ml iohexol 240 I/ml (Omnipaque®, GE Healthcare) or 
ioversol 240 I/ml (Optiray®, TYCO), was injected through the side port of the 3-way stop cock 
under strict aseptic conditions. 
Statistics 
Descriptive statistics were used in all five studies. The groups were compared with chi-square test 
(χ2 test) or Fisher's exact test for categorical data, with t-test or two-way repeated-measures analysis 
of variance (RM ANOVA) for continuous, normally distributed data, and with the Mann-Whitney 
U test (MW-U) for non-parametric data (I–IV). For example, VAS scores were analyzed with the 
MW-U and changes in motor response thresholds over time (EST1-6, Study V) with the two-way 
RM ANOVA. As appropriate, 95% confidence intervals (95% CI) were calculated. A p-value (p) 
<0.05 was taken as being statistically significant.  
Statistical calculations were performed using the SigmaStat® for Windows® computer program 
(Version 2.03, SPSS Inc., Chicago, IL, USA) (I) or the StatView® for Windows® computer program 
(Version 5.0.1., SAS Institute Inc., Cary, NC, USA) (II–V). Where appropriate, 95% CI for 
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population medians were computed with the software Confidence Interval Analysis (Version 2.1.1, 
by Bryant TN, University of Southampton, UK, 2000).  
Power analysis 
For Studies I–IV, a power analysis was performed based on a significance level α=0.05, a power of 
80%, and a two-sided (I–III) or one-sided (IV) test.  
Study I 
The estimation of the sample size was based on previously published data [Niemi and Breivik 
1998]. A 40% reduction of VAS pain scores was taken as being clinically relevant in the study 
patients, i.e., a reduction from 50 mm to 30 mm on a 100-mm VAS scale with a standard deviation 
of 25 mm; thus, the estimated sample size was 25 patients in each group. 
Study II 
As no epidural analgesia studies with similar adrenaline containing drug mixtures in patients after 
TKA were available, the sample size calculation was based on historical data [Silvasti and Pitkänen 
2001; Förster and Rosenberg 2004]. With an average rescue requirement of 16 mg oxycodone i.m. 
(SD 11 mg) and assuming a mean reduction of 50% as being clinically significant, 31 
patients/group were found necessary to detect statistical significance. In order to allow for possible 
drop-outs, a total of 35 patients were allocated to each group. 
Study III 
Sample size was calculated based on estimations of the primary end point, i.e., the amount of the 
rescue medication (oxycodone i.m.): Using previous experience (mean 11 mg, SD 8 mg) and 
assuming a mean reduction of 50% (5.5 mg) as clinically significant, 34 patients/group were 
considered necessary to detect statistical significance. 
Study IV 
A total of 20 patients per group were considered necessary to detect statistical significance based on 
previous experience with bupivacaine [Bachmann et al. 1997]: mean difference between the groups 
23% when comparing CSPA with bupivacaine 2 mg/h alone versus bupivacaine 1 mg/h and 
morphine 8 µg/h with respect to the number of patients scoring a modified Bromage score of 2 or 3. 
The latter study was used as basis for the power analysis due to lack of available comparative data 
for ropivacaine with CSPA. To allow for possible drop-outs, 23 patients were allocated to each 
group. 
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Results 
Patients and surgery 
Patients enrolled, randomized, and analysed 
Altogether, 269 patients were entered into the Studies I–V during 2001–2006. Of these, 239 
patients were enrolled into the randomized Studies I–IV, and 30 others to the diagnostic Study V. In 
one patient belonging to Study IV, the identification of the intrathecal space failed at lumbar 
puncture (Table 15). This patient was replaced by the next recruited patient with regard to the 
randomization code which still was sealed at that time. The remaining 238 patients were 
randomized in Studies I–IV as shown in Table 15. In addition, this table provides an overview of 
reasons why 16 of these 238 patients were excluded from data analysis (total drop-outs). The 
patients who withdrew their consent during the course of the study (Table 15) did not do so because 
of possible adverse outcomes or clinically significant side-effects, but rather because they preferred 
to be no longer bound by the study protocol. One patient (Study II, Group RF) received, due to 
human error, an epidural drug infusion with a higher than intended fentanyl concentration. Despite 
the higher fentanyl concentration (6 µg/ml), this patient did well and showed no obvious opioid 
related side-effects except itching on his chest. He was withdrawn from the study when the error 
was recognized during the stay at the PACU.  
The data of 222 of the 238 randomized patients were analyzed (I–IV) (Table 15). These 222 
patients were divided into 178 patients having had CEA (I–III), and 44 others who received CSPA 
(IV). Of the former group, 24 patients (Table 15) dropped out of the study later. Their data were, 
nevertheless, included in the statistical analysis until the time of their withdrawal. The reasons for 
being withdrawn prematurely included technical problems (n=5), postoperative confusion (n=4; in 
two of these individuals, postoperative confusion led to catheter dislodgment), accidental catheter 
dislodgment (n=2), and insufficient pain relief (n=2). The time points of premature withdrawals are 
specified for each individual in the original publications (Table 2 in Study I; Table 1 in Study II; 
Table 1 in Study III). All 44 patients who entered the CSPA part of Study IV completed it.  
In Study V, 25 of the 30 patients received CEA. In two of these 25 patients receiving CEA, the 
catheter became accidentally dislodged. In the remaining five patients of Study V, the catheter was 
located either not within the spinal canal (n=4) or intrathecally (n=1). Despite these unwanted 
outcomes (paravertebral and intrathecal catheter position; premature catheter dislodgment), all 30 
patients were included in the analysis with respect to EST (Study V) and data synthesis of Studies 
I–V.  
Table 16 summarizes numbers of patients involved in Studies I–V. 
Demographic data and premedication 
Demographic data are shown in Table 17. Patients undergoing arterial bypass surgery (I and IV) 
were on average slightly older than those who underwent knee replacement (II and III). Regarding 
the body mass index (BMI), there was a reversed trend with more obese patients being in Studies II 
and III (mean 28 kg/m2) as compared to patients in Studies I and IV (mean 25 kg/m2) (Table 17). 
Patients younger than 40 years (arbitrary cut-off) were found only in Study V (five patients). The 
overall distribution for physical status was as follows: ASA class I n=18, ASA class II n=65, ASA 
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class III n=162, and ASA class IV n=7. Patients in Studies I and IV were on average in a worse 
condition of health than patients in Studies II–III and V based upon ASA class data (Table 17).  
Treatment groups and control groups did not statistically differ from each other as regards 
patient characteristics and premedication within each Study I–IV (Table 17) except that patients in 
Group RFA were heavier and received higher doses of the premedication drug than those in Group 
RF in Study I (Table 17). 
 
Table 15. Number of patients enrolled, randomized, and forwarded to statistical analysis in the randomized, 
controlled, and double-blinded studies (I–IV). 
 Study I Study II Study III Study IV Total 
Studies 
I–III 
Total 
Studies 
I–IV 
Enrolled 50 70 72 47 192 239 
Failure to identify 
intrathecal 
space 
– – – 1 – 1 
Group RFA RF RFA RF RFC RF RM R   
Randomized 25 25 35 35 36 36 23 23 192 238 
Total drop-out 4 – 4 3 – 3 1 1 14 16 
- Failure of con-
tinuous neur-
axial analgesia 
2 – 4 2 – 1 – – 9 9 
- Withdrawal of 
consent 
1 – – – – 1 1 – 2 3 
- Inadvertent 
protocol 
violation 
– – – 1a – 1b – – 2 2 
- Others 1c – – – – – – 1d 1 2 
Forwarded to 
statistical 
analysis 
21 25 31 32 36 33 22 22 178 222 
Drop-out during 
continuous 
postoperative 
neuraxial 
analgesia 
1 8 6 4 3 2 – – 24 24 
           
Data are numbers of patients. RFA=Epidural infusion of ropivacaine, fentanyl, and adrenaline. RF=Epidural infusion of 
ropivacaine and fentanyl. RFC=Epidural infusion of ropivacaine, fentanyl, and clonidine. RM=Spinal infusion of 
ropivacaine and morphine. R=Spinal infusion of ropivacaine alone.      
aWrong epidural drug mixture.  
bProtocol violation concerning the epidural infusion regimen.  
cSigns of myocardial ischaemia and acute moderate heart insufficiency, treated with various drugs including repeated 
i.v. opioid. Patient recovered without detectable increase of cardiac enzymes. 
dConversion to general anaesthesia.  
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Table 16. Summary regarding number of patients involved in Studies I–V. 
 No. of patients Comment 
Enrolled 269 Studies I–V 
Randomized 238 Studies I–IV 
Without randomization 30 Study V 
Disposed to puncture of epidural space 
and application of catheter 
222 192 patients Studies I–III 
+ 30 patients Study V 
CEA started 217 192 patients Study I–III 
+ 25 patients Study V 
Disposed to puncture of intrathecal space 
with intention to place spinal catheter 
47 Study IV 
Successful application of spinal catheter 
followed by CSA for surgery 
46 Study IV 
Administration of CSPA 44 Study IV 
Forwarded to detailed analysis 252 178 patients Studies I–III 
+ 44 patients Study IV 
+ 30 patients Study V 
CEA=Continuous epidural analgesia. CSA=Continuous spinal anaesthesia. CSPA=Continuous spinal postoperative 
analgesia.  
 
 
  
Table 17. Demographic data and premedication. 
 Study I Study II Study III Study IV Study V 
Group RFA RF RFA RF RFC RF RM R  
No. of patients  21 25 31 32 36 33 22 22 30 
Gender (female/male) 6/15 12/13 25/6 22/10 24/12 23/10 10/12 11/11 14/16 
Age (years) 70 (9) 
(51–81) 
71 (13) 
(41–88) 
67 (11) 
(46–85) 
69 (9) 
(42–82) 
70 (9) 
(43–83) 
68 (11) 
(38–82) 
72 (10) 
(51–94) 
72 (11) 
(51–95) 
57 (17) 
(19–82) 
Weight (kg) 76 (13) 67 (12)* 76 (13) 77 (13) 76 (14) 81 (17) 74 (15) 68 (14) 74 (16) 
Height (cm) 172 (9) 167 (8) 166 (9) 167 (10) 166 (10) 167 (11) 171 (7) 165 (11) 171 (8) 
BMI (kg/m2) 26 (3.5) 24 (3.5) 28 (3.9) 28 (3.2) 27 (4.1) 29 (3.8) 25 (4.7) 25 (4.7) 25 (4.1) 
ASA class (I/II/III/IV) NA/0/21/0 NA/0/22/3 7/7/17/NA 4/11/17/NA 0/13/23/NA 3/13/17/NA NA/1/21/0 NA/0/18/4 4/20/6/0 
Premedication p.o. 
diazepam (mg) 
10 (6.9/10) 7.5 (5/8.1)# 15 (10/15) 15 (10/15) 7.5 (5/10) 10 (5.7/10)§ 8.8 (5/10) 7.5 (5/10) 10 (10/10) 
Data are number of patients, mean (SD), or median (25th/75th percentiles). For age data are mean (SD) (range). RFA=Epidural infusion of ropivacaine, fentanyl, and 
adrenaline. RF=Epidural infusion of ropivacaine and fentanyl. RFC=Epidural infusion of ropivacaine, fentanyl, and clonidine. RM=Spinal infusion of ropivacaine and 
morphine. R=Spinal infusion of ropivacaine alone. BMI=Body mass index. ASA class=American Society of Anesthesiologists physical status classification. NA=Not 
applicable.     
*p=0.027, t-test.      
#p=0.017, MW-U test.     
§p=0.6, MW-U test. 
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Surgery 
Relevant surgery data are summarized in Table 18 (I and IV) and Table 19 (II and III). The surgical 
procedures performed in Study V were thoracotomy (n=4), upper abdominal (n=4), and lower 
abdominal (n=22).  
 
Table 18. Surgery related results pertaining to Studies I and IV. 
 Study I Study IV 
Group RFA RF RM R 
Duration of surgery (min) 171 (67) (101–375) 187 (82) (90–434) 164 (66–299) 182 (89–327) 
Duration ≥3 h (no.) 8 15 9 11 
Type of bypass 
Vein (no.) 
Prosthesis (no.) 
 
13 
8 
 
22 
3 
 
7 
15 
 
8 
14 
Data are mean (SD) (range) or number of patients. RFA=Epidural infusion of ropivacaine, fentanyl, and adrenaline. 
RF=Epidural infusion of ropivacaine and fentanyl. RM=Spinal infusion of ropivacaine and morphine. R=Spinal 
infusion of ropivacaine alone.       
 
 
Table 19. Surgery related results pertaining to Studies II and III. 
 Study II Study III 
Group RFA RF RFC RF 
Duration of surgery (min) 121 (26) 122 (27) 89 (28) 98 (21) 
Tourniquet 
Duration (min) 
Pressure (mmHg) 
 
101 (22) 
250 (250–300) 
 
101 (19) 
250 (250–300) 
 
77 (20) 
320 (300–350) 
 
86 (17) 
320 (300–360) 
Data are mean (SD) or median (range). RFA=Epidural infusion of ropivacaine, fentanyl, and adrenaline. RF=Epidural 
infusion of ropivacaine and fentanyl. RFC=Epidural infusion of ropivacaine, fentanyl, and clonidine.  
 
Anaesthesia and intraoperative data  
Anaesthesia 
All surgical procedures were successfully performed under the planned regional anaesthesia 
technique planned, i.e., SSA together with epidural top-ups, when needed, in Studies I–III and CSA 
in Study IV (except one conversion to GA, Table 15). Study and control groups did not differ in a 
statistically significant way regarding the number of epidural top-ups given intraoperatively in 
Studies I–III (e.g., 6 top-ups in Group RF and 1 top-up in Group RFA in Study II; p=0.1, Fisher’s 
exact test). However, in Study IV, patients from Group RM received higher amounts of intrathecal 
ropivacaine during surgery as compared to Group R despite comparable duration of surgery: 
median (range) 34 (18.8–41.3) mg versus 23 (15.0–41.3) mg. This difference achieved statistical 
significance (p=0.03, MW-U) with a median difference of 7.5 (95% CI 0–11.3) mg. Apart from the 
latter difference, treatment and control groups were comparable within Studies I–IV with regard to 
other intraoperative parameters, such as sedatives, vasoactive drugs, and the time interval from 
spinal anaesthesia being done to start of the continuous neuraxial analgesia.  
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Spinal anaesthesia spread slowly in Study IV; hypoaesthesia to cold was found at the T9–T10 
level after 20 (range 15–25) min (no difference between groups). Because of the slow spread, slight 
head-up tilt of the operating table was made in five patients. Thirteen patients experienced mild 
pain during skin incision (no inter-group difference) and were treated with fentanyl i.v. (11 
patients), intrathecal top-ups (12 patients), and with local infiltration of lidocaine 10 mg/ml (4 
patients).  
In Study I, 26 of 45 patients had epidural top-ups after SSA, while in Study IV, 26 of 44 
patients received intrathecal top-ups after the first hour of CSA. In Study IV, as the operation 
neared its completion, 3 patients although still maintaining an adequate sensory block, moved their 
legs to such an extent that it disturbed the surgeons.  
Haemodynamics during first hour (Study IV) 
Mean arterial blood pressure (Figure 2), CVP, and heart rate decreased slightly during the first hour 
after starting CSA (for all parameters p<0.0001, RM ANOVA). During the first hour of CSA, four 
patients received phenylephrine i.v. for hypotension with the total doses being less than 0.2 mg. 
Mean CVP values were 4–7 mmHg throughout the initial 60 min observation period.  
 
Figure 2. Mean arterial blood pressure (MAP) during first 60 min into CSA (IV). 
 
CSA=Continuous spinal anaesthesia. Data originate from the 44 patients who received continuous spinal postoperative 
analgesia (CSPA) in Study IV. Symbols are mean and SD. Open circles are absolute lowest MAP observed at each time 
point. The decrease in MAP over time was statistically significant (p<0.0001, F>25, RM ANOVA). 
 
Anaesthesia for revision surgery (Study IV) 
On four occasions in Study IV, surgical revision became necessary early in the postoperative phase 
because of wound haematoma formation (1 in Group RM, 3 in Group R). CSPA was thus 
interrupted and increments of 0.5–1.0 ml of ropivacaine 7.5 mg/ml were given through the spinal 
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catheter to establish surgical anaesthesia. The interventions lasted 20–60 min and CSPA was again 
started when voluntary contractions of the thigh muscles were seen.  
Postoperative pain relief 
Failure of CEA or insufficient CEA occurred in nine of the 192 patients (5%) in Studies I–III. CEA 
produced adequate pain relief in all 25 patients of Study V in whom epidurography showed the tip 
of the catheter in the epidural space. Analgesia was adequate in all CSPA patients in Study IV. 
Postoperative analgesia in Studies I–V 
Study I 
In Study I, the VAS pain values at rest and on movement did not differ significantly between the 
two groups at any of the observation times. Furthermore, the addition of adrenaline to the infusion 
had no effect on the need for rescue medication. The mean (SD) oxycodone i.m. consumption over 
48 h was 3.3 (5.2) mg in seven patients belonging to Group RFA as compared to 3.7 (5.4) mg in 
nine patients belonging to Group RF (not significant). 
 
Figure 3. Amounts of infusion administered epidurally during CEA in Study II. 
 
CEA=Continuous epidural analgesia. RFA=Epidural infusion of ropivacaine, fentanyl, and adrenaline. RF=Epidural 
infusion of ropivacaine and fentanyl. Day 0=Day of surgery. Day 1 and 2=First and second postoperative day, 
respectively. Symbols are mean with SD. The two factors group and time were connected with each other in a 
statistically significant way (p=0.02, F=2.4, two-way RM ANOVA). 
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Study II 
In Study II, a significantly higher amount of the epidural infusion was administered in Group RFA 
as compared to Group RF (Figure 3). The difference between the groups was statistically significant 
at each interview time with mean (SD) cumulative amounts being 283 (68) ml in Group RFA and 
243 (70) ml in Group RF (mean difference 40 (95% CI 5–75) ml; p=0.025, t-test). The period from 
the start of the epidural infusion to the first interview at 18:00 Day 0 was somewhat longer in Group 
RFA than in Group RF; this difference, however, did not reach statistical significance (Table 20). 
The total amounts or number of doses of oxycodone i.v. and i.m. were similar in both groups of 
Study II; as were the combined number of i.v. and i.m. oxycodone doses and epidural boluses 
(Table 20). Median VAS pain scores were ≤3 at rest at all time points, except in RFA at 24:00 Day 
0 (Figure 4). There was a statistically significant difference between the groups regarding pain 
scores when moving at 24:00 Day 0 and at 06:00 Day 2, when higher values were seen in Group 
RFA (Figure 4). 
 
Table 20. Results related to pain management during CEA in Study II. 
 Group RFA Group RF p-value 
Time from spinal anaesthesia to start of epidural infusion (min) 216 (33) 222 (56)  
Time from start of epidural infusion to 18:00 Day 0 (min) 297 (91) 244 (56) 0.06 (t-test) 
Epidural boluses given postoperatively (no.) 3 (1/5) 2 (0.5/3) 0.2 (MW-U) 
Sum of postoperative oxycodone doses i.v. and i.m. (no.) 1 (0/3) 0 (0/1.5) 0.07 (MW-U) 
Sum of postoperative epidural boluses and oxycodone doses 
(no.) 
6 (1.3/8) 3 (1/5) 0.11 (MW-U) 
VAS pain scores ≤3 at rest (yes/no) (no. of patients) 
Until 12:00 Day 1 
Until 12:00 Day 2 
 
5/26 
4/27 
 
9/23 
7/25 
 
Separate breakthrough pain episodes (no.) 
VAS pain score at rest 4–6 
VAS pain score at rest 7–10 
 
3 (1/4) 
0 (0/2) 
 
1.5 (1/3) 
0 (0/1) 
 
Patients’ satisfaction (no. of patients)a 
18:00 Day 0  
24:00 Day 0 
 
21/4/5/1 
10/7/6/5 
 
17/12/0/0 
12/15/1/2 
 
0.02 (χ2 test) 
0.048 (χ2 test) 
Patients’ overall satisfaction with pain management regimenb 9 (8/10) 9 (9/10) 0.12 (MW-U) 
Data are mean (SD), median (25th/75th percentiles), or number of patients or observations. CEA=Continuous epidural 
analgesia. RFA=Epidural infusion of ropivacaine, fentanyl, and adrenaline. RF=Epidural infusion of ropivacaine and 
fentanyl. Day 0=Day of surgery. Day 1 and 2=First and second postoperative day, respectively. VAS=Visual analogues 
scale.  
aKey for patients’ satisfaction with pain treatment: very satisfied / satisfied / cannot say / not satisfied. 
bPatients’ overall satisfaction estimated on a numerical rating scale from zero (worst) to ten (best). 
49 
 Figure 4. VAS pain scores at rest (A) and during movement (B) in Study II. 
 
Box plots are medium with 25th/75th percentiles; whiskers are 10th/90th percentiles. VAS=Visual analogues scale. 
RFA=Epidural infusion of ropivacaine, fentanyl, and adrenaline. RF=Epidural infusion of ropivacaine and fentanyl. 
Day 0=Day of surgery. Day 1 and 2=First and second postoperative day, respectively. *p-values 0.03–0.003, MW-U. 
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Study III 
In Study III, patients of Group RFC received a significantly smaller amount of the epidural drug 
infusion as compared to Group RF (p=0.01, F=6.49, RM ANOVA). The difference between the 
groups was statistically significant at each interview time beginning at 24:00 Day 0. The mean (SD) 
cumulative amounts of infused drugs were 100 (17) ml in Group RFC and 113 (20) ml in Group RF 
(mean difference 13 (95% CI 4–22) ml; p=0.025, t-test). 
 
Figure 5. Total amounts of intramuscular oxycodone given postoperatively during Study III. 
 
RFC=Epidural infusion of ropivacaine, fentanyl, and clonidine. RF=Epidural infusion of ropivacaine and fentanyl.  
 
At the same time, patients of Group RFC received less intramuscular oxycodone (Figure 5) 
with a median amount (25th/75th percentiles) of 0 (0/7) mg in RFC, as compared to 7 (0/12) mg in 
RF. This difference achieved statistical significance (p=0.027, MW-U) with a median difference of 
3 (95% CI 0–7) mg. One patient in Group RFC received an epidural bolus of ropivacaine as 
additional medication when compared to three patients of Group RF who received six doses of 
ropivacaine. Other parameters related to pain management during CEA in Study III are summarized 
in Table 21. VAS pain scores at rest and during movement did not differ statistically at any 
interview point except at 24:00, when lower pain scores were observed in RFC (p<0.025, MW-U).  
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 Table 21. Results related to pain management during CEA in Study III. 
 Group RFC Group RF 
VAS pain scores ≤3 at rest until 12:00 Day 1 (yes/no) (no. of patients) 15/21 6/27 
Separate breakthrough pain episodes (no.) 
VAS pain score at rest 4–6 
VAS pain score at rest 7–10 
 
32 (17 patients) 
13 (8 patients) 
 
49 (21 patients) 
31 (17 patients) 
Patients receiving oxycodone i.m. (yes/no) (no.) 16/20 23/10* 
Patients’ overall satisfaction with pain management regimena 9 (8/10) 8 (5.8/10)# 
Data are number of patients or observations, or median (25th/75th percentiles). CEA=Continuous epidural analgesia. 
RFC=Mixture of ropivacaine, fentanyl, and clonidine. RF=Mixture of ropivacaine and fentanyl. Day 1=First 
postoperative day. VAS=Visual analogues scale.  
aPatients’ overall satisfaction estimated on a numerical rating scale from zero (worst) to ten (best).  
*p=0.06, χ2 test  
#p=0.08, MW-U 
 
Study IV 
In Study IV during CSPA, on average, a larger volume of the study drug infusion was given 
intrathecally in Group RM as compared to Group R: median (25th/75th percentiles) 8.8 (8.4/9.0) ml 
versus 8.4 (8.1/8.7) ml (p=0.03, MW-U, median difference 0.4 (95% CI 0.04–0.7) ml). Pain relief 
was comparable in both groups as noted by VAS pain scores at rest and during movement. The 
consumption of oxycodone rescue medication did not differ significantly between Groups RM and 
R with median (25th/75th percentiles) numbers of oxycodone doses of 3 (1/7) and 5 (3/8), 
respectively (p=0.12, MW-U). No oxycodone was needed in the study period in 5 patients from 
Group RM and 11 others from Group R (p=0.12, χ2 test with Yates’ continuity correction). After 
discontinuing the spinal infusion on the first postoperative day, three patients from each of these 
groups did not get any oxycodone during the following 24 hours.  
Study V 
In Study V, there was adequate pain relief in all 25 patients given CEA. Two of these 25 individuals 
developed asymmetric and insufficient epidural analgesia which was successfully treated with 
epidural top-ups. The median (25th/75th percentiles) number of epidural boluses given on the 
surgical ward was 0 (0/1). On the surgical ward, a single patient needed rescue oxycodone i.m. The 
median (25th/75th percentiles) PHH-scores were 1 (0/3), 1 (1/3), and 1 (0/2) on the morning and 
afternoon of Day 1 and on the morning of Day 2, respectively. Correspondingly, the highest VAS 
pain scores were 2 (0/3.3), 3 (1/3.3), and 2 (0/2).  
Patients’ satisfaction with pain management  
There were no significant inter-group differences regarding the patients’ satisfaction with the pain 
treatment as determined by the interviews in Studies I–IV except for patients in Study II whose 
satisfaction was significantly higher in Group RF as compared to Group RFA on the first evening 
and during the first night after surgery (Table 20).  
Data pertaining to overall satisfaction with the pain management regimen noted at the end of 
Studies II and III are presented in Table 20 and Table 21 with no statistical differences noted 
between the groups. 
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Comparison of Studies I and IV and of Studies II and III 
Study I versus Study IV 
Examining the VAS scores experienced by moving in Studies I and IV during the first 24 hours, 
there seemed to be a trend towards higher pain levels with CSPA when compared to CEA (Figure 
6). However, the patients’ overall satisfaction with pain treatment was good to excellent in both 
studies (Table 3 in Study I and Table 4 in Study IV). The low VAS pain scores at rest in Studies I 
and IV demonstrated no difference between the two trials.  
 
Figure 6. VAS pain scores during movement acquired in Studies I and IV during the first 24 hours after surgery. 
 
VAS=Visual analogue scale. RF=Epidural infusion of ropivacaine and fentanyl. RFA=Epidural infusion of ropivacaine, 
fentanyl, and adrenaline. R=Spinal infusion of ropivacaine alone. RM=Spinal infusion of ropivacaine and morphine. 
Day 0=Day of surgery. Day 1= First postoperative day. 
 
Study II versus Study III 
The VAS pain scores from Studies II and III acquired during the first four interviews performed at 
6-hours intervals revealed no clear pattern as to which pain relief was preferable (Figure 7 and 
Figure 8). However, the pain scores in Group RFA of Study II tended to be higher and those of 
Group RFC of Study III lower on the first evening and night after surgery.  
Regarding the patients’ overall satisfaction with the management of pain, no difference was 
found between Study II and Study III (Table 20 and Table 21). 
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 Figure 7. VAS pain scores at rest in Studies II and III at the first four interviews performed at 6-hour intervals. 
 
VAS=Visual analogues scale. RF=Epidural infusion of ropivacaine and fentanyl. RFA=Epidural infusion of 
ropivacaine, fentanyl, and adrenaline. RFC=Epidural infusion of ropivacaine, fentanyl, and clonidine. Day 0=Day of 
surgery. Day 1= First postoperative day. 
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 Figure 8. VAS pain scores during movement in Studies II and III at the first four interviews performed at 6-hour 
intervals. 
 
VAS=Visual analogues scale. RF=Epidural infusion of ropivacaine and fentanyl. RFA=Epidural infusion of 
ropivacaine, fentanyl, and adrenaline. RFC=Epidural infusion of ropivacaine, fentanyl, and clonidine. Day 0=Day of 
surgery. Day 1= First postoperative day. 
 
Side-effects and complications 
No serious side-effects or complications with persistent sequelae were observed in any of the 
Studies I–V.  
Sedation 
Generally, the degree of sedation was low in all Studies I–V. Sedation of grade 3 was registered 
once in both Study I (Group RF) and Study II (Group RF), and twice in Study III (one individual in 
each Group RF and RFC). Vital signs, including respiratory rate, were stable at these points of time 
and the patients scored only low sedation grades thereafter. Additionally, one patient from Group 
RM in Study IV once scored sedation of grade 3. This happened in the PACU, 8 h after the start of 
CSPA and shortly after the patient had received haloperidol 5 mg i.v. for restlessness and 
confusion.  
In Study III, the addition of clonidine did not increase the sedation scores in Group RFC as 
compared to RF. One-third of all patients belonging to Study III felt ‘drowsy to a disturbing extent’ 
at some point during CEA (Table 13) with no inter-group statistical difference being observed. 
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Paraesthesia, bloody tap, neurological symptoms 
In Study IV, 11 of 46 patients experienced short lasting, mild paraesthesia during lumbar puncture 
or while advancing the catheter. A bloody tap occurred during lumbar puncture in three patients of 
Study IV, however, once free flow of CSF was obtained, the macroscopic appearance of the latter 
was clear on all occasions.  
The one patient from Study V, in whom dura perforation at a thoracic level occurred during 
catheter placement was observed for 5 days after the event and did not reveal any neurological signs 
or symptoms. 
Haemodynamic changes 
Overall, haemodynamic changes observed during Studies I–V did not differ from those otherwise 
seen during the routine use of continuous neuraxial analgesia. In any case, when pronounced 
haemodynamic changes occurred they responded well to treatment.  
In Study I, eight patients required the rate of their epidural infusion to be halved, in five of 
them the infusion rate was returned to the initial level when haemodynamics had stabilized. 
Although this observation showed no difference between the groups, it is important because the 
plasma concentrations of ropivacaine and fentanyl became affected (see below Discussion). 
In Study III, mean arterial pressure (MAP) and heart rate measured at the interviews were 
slightly lower in Group RFC as compared to Group RF (statistically significant for the MAP with a 
mean difference of 5 mmHg (p<0.002, F=10.5, RM ANOVA)). Additionally, when taking into 
account blood pressure values registered apart from those of the predetermined interviews, systolic 
blood pressure less than 90 mmHg was observed more often in Group RFC than in RF (Table 4 of 
Study III). Two patients of Group RFC received three doses of ephedrine i.v. (5 to 10 mg) on the 
ward during CEA compared to none of those in Group RF.  
In Study IV, haemodynamic parameters did not differ statistically between Group R and Group 
RM. When the spinal infusion was reduced during CSPA, it was mainly to manage hypotension and 
on some occasions due to a pronounced motor block that had ensued (page 397 and Table 3 of 
Study IV).  
Motor weakness 
Motor blockade in Studies I–III was rarely encountered and unaffected by the addition of either 
adrenaline or clonidine. For instance, the steady decrease in motor block during Study II is shown 
in Figure 9: Deeper degrees of motor blockade were more often noted during the stay in the PACU 
and grade 3 did not occur after 18:00 on the day of surgery. In Studies II and III, routine 
physiotherapy was begun in the vast majority of patients in the morning of Day 1. On six occasions 
(3 patients per group) of Study III, only limited exercises could be made due to a slight motor 
block, while in one patient of each group physiotherapy was postponed because of the occurrence 
of prominent leg weakness. The infusion rate during CSPA was diminished to counter the marked 
motor block in four patients of Group R and in one patient from Group RM (Figure 2 in Study IV).  
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 Figure 9. Motor blockade during epidural infusion in Study II. 
 
RF=Epidural infusion of ropivacaine and fentanyl. RFA=Epidural infusion of ropivacaine, fentanyl, and adrenaline. 
Motor blockade as evaluated with a modified Bromage scale [Bromage 1965]: Grade 1=Just able to move knees. 
Grade 2=Able to move feet only. Grade 3=Unable to move feet and knees. 
 
PDPH 
No patient, including the two individuals in whom the dura was punctured (Table 22), complained 
of PDPH. A 70-year old patient of Group RFC in Study III suffered severe headache on Day 1; 
computer tomography of the head was performed which revealed no pathology. Intravenous 
diazepam improved her situation. Six patients belonging to Study IV reported mild, though 
transient, headaches and lower back pain (Table 4 of Study IV). 
PONV 
The incidence of PONV did not significantly vary between the groups at any of the predetermined 
interviews in Study III. However, eight patients suffered vomiting (11 single episodes) in Group 
RFC as compared to one patient of Group RF. 
Pruritus 
Pruritus was less frequent in Group RFC than in Group RF at one interview with, however, no 
difference in the consumption of oral hydroxyzine (Table 4 of Study III). 
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Postoperative confusion 
A number of patients experienced postoperative confusion. Two of these of Study I (both Group 
RF) removed their epidural catheters. Two others belonging to Study II (one from each group) also 
became confused and were excluded from further analysis. A 76-year old patient of Group RFC 
became seriously confused in the afternoon and evening of Day 1; i.e., several hours after the study 
infusion had been turned off. The following day, he was again co-operative without recall of the 
previous day. In Study IV, several patients showed signs of postoperative confusion of a mild and 
transient nature that did not lead to exclusion from the study (no inter-group statistical difference). 
Technical problems  
Technical problems are summarized in Table 22.  
 
 Table 22. Technical problems encountered during Studies I–V. 
 Study I Study II Study III Study IV Study V 
Identification of assumed epidural 
space by LOR technique and 
application of catheter 
All 50, including one dura tap 
followed by puncture at 
different lumbar level  
All 70 All 72 NA All 30, however, one 
dura punctured while 
threading catheter 
Failed identification of intrathecal 
space 
0 0 0 1 NA 
One or 2 / 3 or more punctures 
needed to identify intrathecal 
space 
NA NA NA 37 / 9 NA 
Successful application of spinal 
catheter 
NA NA NA 46 of 46, however, initial resistance 
in two with successful threading of 
catheter after withdrawal of needle 
by 1–2 mm 
NA 
Catheter dislodgement 4 (two combined with post-
operative confusion) 
0 0 0 2 (during ambulation 
on Day 2) 
Leakage at some point of catheter-
adapter-infusion line assembly 
0 2 1 4 (all related to tightness of seal 
between catheter and adapter) 
0 
Catheter-adapter disconnection 1 0 0 0 0 
Leakage of epidural infusion fluid 
from puncture site 
1 1 0 NA 0 
Catheter kinking 0 0 3 (two solved by rearranging 
fixation tapes; one led to early 
drop-out) 
2 0 
Technical failure of infusion pump 0 0 1 (defect pump replaced) 0 0 
Data are number of patients. LOR=Loss-of-resistance. NA=Not applicable or not available. Day 2=Second postoperative day. 
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Plasma concentrations and ABPI (Study I) 
The plasma concentrations of both fentanyl and ropivacaine increased over time (Figure 2 in Study 
I). The ropivacaine concentration was significantly higher at 6 h in Group RF as compared to Group 
RFA (p=0.01, t-test). No further difference in ropivacaine concentrations was noted on the first and 
second postoperative days (p>0.35, t-test). The fentanyl plasma concentrations, however, remained 
similar in both groups at each study period (p>0.55, t-test). 
Complete ABPI data was obtained in 17 patients of each group with no difference occurring 
between the groups.  
Results of Study V 
Epidurographies 
Table 23 summarizes the positions of the epidural catheter tips as confirmed by epidurography. 
Figure 2 of Study V shows some characteristic findings of epidurography: a) positive 
epidurography with the catheter tip epidurally (Figure 2A and 2B); b) catheter dislodgment but with 
catheter tip still in situ (Figure 2C and 2D); c) catheter tip at the level of an intervertebral foramen 
(Figure 2E); and d) catheter tip outside of spinal canal (Figure 2F).  
 
Table 23. Positions of epidural catheter tips as confirmed by epidurography in Study V. 
Subgroup No. of patients Initial position (Epidgr1) Position Day 2 (Epidgr2) 
Epid-Epid 22 Epidural Epidural 
Cath-Dis 2 Epidural Catheter dislodged 
Inter-Foram 1 Intervertebral foramen Epidural 
Paravert 4 Paravertebral NA 
Intrathec 1 Intrathecala NA 
Epidgr1=Epidurography on day of surgery before start of continuous epidural analgesia. Epidgr2=Epidurography on the 
second day after surgery. Day 2=Second postoperative day. NA=Not applicable.  
aAll catheter positions were verified by epidurography except for the patient in whom the catheter tip was found in the 
subarachnoid space and cerebrospinal fluid appeared. The presence of the latter was confirmed with a glucose reagent 
strip. 
 
Motor response to EST 
In all individuals, EST1 elicited a motor response: In 28 instances, the Category of motor response 
was in accordance with the spinal column level at which the catheter had been placed; while in the 
remaining two individuals, the Category and the level did not match (nevertheless, they were 
adjacent). In six patients (all Subgroup Epid-Epid), during EST2–6, the Category of motor response 
shifted to a neighbouring Category as compared to EST1. At times, the site of the twitching moved 
within one Category, for example, when comparing EST1 to EST2.  
The current required to stimulate twitching was, on average, higher under the influence of 
epidurally administered local anaesthetic when compared to EST1 (Figure 10). Still, several times 
the EST2 thresholds were somewhat lower as compared to EST1 (Table 2 of Study V). The average 
threshold had virtually returned to EST1 level when EST6 was carried out (mean (SD) 128 (40) min 
after interruption of epidural infusion) (Figure 10). During 107 of 122 measurements with the 
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catheter tip being located epidurally, EST yielded twitching despite earlier or simultaneous 
administration of the local anaesthetic (EST2–6) (Figure 10). 
 
Figure 10. Threshold current needed to elicit sensory and motor response during EST1-6 in Study V. 
 
Only values of measurements where the catheter tip was considered to be in the epidural space based on epidurography. 
Box plot data are medium (solid line), mean (dotted line), and 25th and 75th percentiles, whiskers are 10th and 90th 
percentiles. EST was performed at the time points EST1–6 (see Figure 1). When calculating box plots, the denominator 
varied depending on the number of individuals in whom no motor response could be elicited (see numbers at bottom of 
figure). Changes in motor response thresholds over time were statistically significant. On average, higher currents were 
needed because of the influence of epidurally administered local anaesthetic (p<0.0001, F=6.5, RM ANOVA, 
differences significant regarding EST3–5 compared to EST1 according to Dunnett post hoc test. Missing data, i.e., no 
threshold values because of absent motor response, were not replaced; therefore, data of only 13 patients were included 
in this analysis of variance). Data pertaining to sensory response are previously unpublished results (J. Förster et al. 
2008).   
 
In one patient of Subgroup Epid-Epid, EST1 produced muscle twitching at 10.5 mA; however, 
PinPrick1-2 revealed a distinct bilateral sensory blockade.  
In two cases, EST1 elicited a unilateral motor response at 0.7 mA (Subgroup Epid-Epid) and 
0.2 mA (Subgroup Inter-Foram). When the catheters were pulled out about 1.0 cm, as 
recommended [Tsui et al. 1998], comparable motor responses were attained at 0.7 mA and 1.2 mA, 
respectively.  
In the two patients of Subgroup Cath-Dis, where the catheters had slipped out of the epidural 
space but yet remained in situ: EST produced no motor response (maximum output 11.9 mA and 
16.0 mA).  
In the four patients of Subgroup Paravert, motor responses became visible at 7.0, 7.9, 8.2, and 
8.9 mA during EST1. In the latter two patients (threshold >8.0 mA), the grounding electrode was 
moved to the contralateral thigh, as recommended [Tsui et al. 1998]. This manoeuvre, however, did 
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not affect the site or the strength of muscle twitching. In two patients belonging to Subgroup 
Paravert, when EST was repeated several hours after the last administration of local anaesthetic, 
one patient demonstrated no twitching (maximum output 14.3 mA), while the second individual 
showed a muscle response at 5.2 mA. 
The patient of Subgroup Intrathec showed a bilateral twitching (simultaneous in the right 
lumbar region as well as the region of the left abdomen). Here, twitching commenced at 0.6 mA 
and gained in strength at 0.7 mA.  
Sensory response to EST 
Data in this paragraph are previously unpublished results (J. Förster et al. 2008). Average 
thresholds needed to elicit sensory response are shown in Figure 10. Both the motor and sensory 
response of EST were usually manifested together within the same area. In some instances, 
however, the patient stated that they felt the sensation under the grounding electrode. For example, 
when inspecting the EST1 reactions of Subgroups Epid-Epid, Cath-Dis, and Inter-Foram, the site of 
the sensory response was in the same area as that of the motor response in only 15 of 25 patients. In 
some patients, the neurostimulation test produced sensory sensations in more than one area (Table 
24). The location of the sensory response often changed even though that of the motor response 
remained unaffected during EST2–6. Patients with sensory response but without twitching are 
presented in Table 24.  
 
Table 24. Data concerning sensory response to epidural stimulation test (EST) and technical aspects during EST. 
 EST1 EST2 EST3 EST4 EST5 EST6 
Sensory response observed at more than one site 7a 3a 2a 2b 4b 5b 
Sensory response but no motor response 0 3 6 8 4 2 
Need to flush catheter-adapter assembly with sterile 0.9% saline 10 5 2 17 1 9 
Need to switch neurostimulator from low to high output mode 6 8 10 14 11 5 
Data are previously unpublished results (J. Förster et al. 2008). Data are number of patients. The patient with 
intrathecal catheter tip position is not included.  
aAll patients of Subgroup Epid-Epid except one of Subgroup Paravert.  
bAll patients of Subgroup Epid-Epid. For Subgroup names refer to Table 23. 
 
Sensory blockade after epidural test doses 
On two occasions, PinPrick2 remained with no or very ambiguous signs of sensory blockade. In one 
of these two patients (Subgroup Paravert, EST1 twitching at 7.9 mA), EST2 and EST3 failed to 
evoke any motor response. TD1 and TD2 did not produce any detectable sensory block. 
Epidurography was performed and showed the catheter to be in a paravertebral position. In the 
second patient (Subgroup Paravert, EST1 twitching at 8.9 mA), EST2 continued to evoke a motor 
response at 9.8 mA, but without any response in EST3. Here, PinPrick2 remained unclear; still GA 
was induced and surgery performed after which the catheter in the paravertebral position was 
confirmed by Epidgr1.  
Additionally, unilateral blockade at PinPrick2 was noted in two subjects (one Subgroup Epid-
Epid, one Subgroup Paravert). In the patient of Subgroup Epid-Epid, EST1–3 produced constant 
twitching at 5.1, 4.2, and 5.3 mA. PinPrick2 revealed a unilateral sensory blockade T5–T11. In the 
patient of Subgroup Paravert, EST1 gave a muscle response at 8.2 mA, but EST2 and EST3 
produced no further muscle response. At PinPrick2, the sensory blockade was localized at T11–L3 
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on the right and possibly at T12 on the left side. In both individuals, it was assumed that the 
epidural catheters were situated epidurally and so GA was induced.  
In still another patient (Subgroup Paravert), EST1 was positive at 7.0 mA, but EST2 and EST3 
failed to elicit any muscle contraction. However, satisfactory bilateral sensory blockade was found 
at PinPrick1–2 and thus the study was continued. 
Technical and other aspects related to EST  
The epidural catheter-adapter assembly often needed flushing with physiological saline because of 
interruption of the electrical circuit (Table 24). During two EST1 measurements, the output of the 
neurostimulator oscillated considerably in spite of repeated saline flushing, and in a further 
instance, when the electrical circuit became disconnected, a slight movement by the patient was 
sufficient to reinstate the current. 
The mean (SD) maximum current delivered in the low output mode was 8.8 (0.9) mA and 
frequently it became necessary to switch the neurostimulator to the high output mode (Table 24). 
However, even then the neurostimulator was often incapable of delivering 16 mA.   
EST2 was interrupted on one occasion because the patient experienced paraesthesia in one leg 
without having any associated visible muscle response. In a second patient, EST6 caused increasing 
pain at the site of surgery. The patient reacted with ‘avoiding’ movements of his upper trunk which, 
in turn, made the determination of the EST threshold unreliable.  
Sometimes, the exact determination of the motor response threshold or the disclosure of the 
motor response as such was influenced by breathing, shivering/tremor, nervous giggling/weeping, 
and abdominal aorta pulsation.  
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Discussion 
Primary hypothesis 
The addition of clonidine to CEA with low-dose ropivacaine and fentanyl somewhat improved 
postoperative analgesia after TKA when compared to the control group (III). CSPA with low-dose 
ropivacaine (maximum 1 mg/h) and morphine (maximum 8 µg/h) or ropivacaine (maximum 2 
mg/h) offered adequate pain relief after peripheral arterial bypass surgery but without any clinically 
important difference between the groups, e.g., with regard to the degree of motor blockade (IV). 
Apart from these results, the primary hypothesis of the present work could not be confirmed, i.e., 
that the efficacy and quality of continuous neuraxial postoperative analgesia would be improved 
with the use of the adjuvant drugs and applied technical means (I–V). The addition of adrenaline 
into a combination of low-dose ropivacaine and fentanyl had no beneficial effect on CEA which 
was given at a lumbar level following vascular surgery (I) or TKA (II), and finally, EST produced 
no clear advantage in providing effective CEA in adult patients undergoing major abdominal 
surgery or thoracotomy (V). 
Adrenaline 
Ineffectiveness of adrenaline in lumbar epidural analgesia (LEA) 
Adrenaline did not aid the efficacy or tolerability of LEA when added in concentrations of 2 and 4 
µg/ml to an infusion of low-dose ropivacaine-fentanyl after arterial bypass surgery of the legs (I) 
and TKA (II), respectively. The patients of the adrenaline Group RFA in Study II with significantly 
higher amounts of epidurally administered drugs tended to have higher pain scores and higher 
numbers of breakthrough pain, and needed more doses of rescue medication. The inter-group 
differences reached statistical significance at two interviews with higher pain scores and less 
satisfaction in patients of Group RFA (II). However, these differences were of a limited extent and 
require cautious interpretation. Focusing on the epidural consumption of drugs after two days, the 
mean difference between the groups was small, 40 ml (95% CI 5–75 ml). In addition, this 
difference might be, at least in part, explained by the fact that RFA patients less frequently required 
intraoperative epidural top-ups and their CEA was begun earlier during day as compared to patients 
of Group RF. On the other hand, these two factors may have occurred by chance and do not explain 
why the difference in epidurally administered drugs continued to grow over the two study days. 
Altogether the data in Study II does not permit one to conclude that the adjunct adrenaline had 
rather antagonistic than additive or synergistic effects with respect to pain relief.  
Analgesic effect through α2-adrenergic receptors in the spinal cord 
The lack of improved analgesia by adrenaline in Studies I and II contradicts earlier reports which 
investigating adrenaline doses of about 10–20 µg/h as an adjuvant to TEA [Baron et al. 1996; 
Niemi and Breivik 1998; Sakaguchi et al. 2000; Niemi and Breivik 2002]. However, it does agree 
with those clinical studies on LEA where adrenaline 0.5 µg/ml [Cohen et al. 1998] and 1.0 µg/ml 
[Cohen et al. 1992] offered no major advantage. In these latter studies, adrenaline doses of about 20 
µg/h were used as compared to Study I where the average dose of adrenaline was 14 µg/h (range 
10–20 µg/h). The negative findings related to adrenaline and LEA have been questioned [Niemi and 
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Breivik 2003; Niemi 2005] insofar as the adrenaline concentrations used were too low [Cohen et al. 
1998; Cohen et al. 1992] or that the baseline pain intensity and thus the assay sensitivity were also 
low (Study I) making it difficult to detect any difference between the treatments. However, even 
with the higher concentration/dosage (4 µg/ml; 12–32 µg/h plus 20 µg as bolus up to two times per 
hour, if needed) and with considerable baseline pain after TKA, adrenaline had no beneficial effect 
on LEA in Study II.  
Curatolo suggested that a possible explanation for the discrepancy between TEA and LEA 
could be because of anatomical differences such as the distance between the sites of administration 
and those of action at the spinal dorsal horn level [Curatolo 2002]. This, in addition to an 
observation made in volunteers [Curatolo et al. 1997] where an adrenaline bolus of 100 µg given 
epidurally at the lumbar level produced an antinociceptive potential, led to the idea for Study II: 
that by increasing the dosage of adrenaline added to LEA it might be possible to increase the spinal 
availability of adrenaline and thus enhance analgesia through an α2-adrenergic receptor effect. But 
the results of Study II show that this did not account for the conditions prevailing in the lumbar 
epidural space. In all probability, many more factors play a part [Curatolo 2002]. These would 
include the width of epidural space and its amount of fat tissue, the loss of adrenaline due to 
absorption [Ramanathan et al. 1995] and metabolism [Kern et al. 1995], altered receptor function in 
the elderly [Guinard et al. 1995], and development of tachyphylaxis to the vasoconstrictive effect of 
adrenaline [Kihara et al. 1999; Miyabe et al. 2002].  
Vasoconstriction of blood vessels by adrenaline in the lumbar epidural space 
It was thought that adrenaline decreases the clearance of epidurally administered drugs by 
constricting the epidural veins and thus decreasing epidural blood flow [Covino and Wildsmith 
1998; Niemi and Breivik 1998]. This would imply that in the presence of adrenaline, the 
concentrations of epidurally administered drugs would be greater in epidural venous blood. 
However, measuring from epidural venous blood by a microdialysis technique in pigs, adrenaline 
had no influence on any plasma pharmacokinetic parameter of epidurally given fentanyl [Bernards 
et al. 2003]. Additionally, Bernards and colleagues stated that perhaps the effect of adrenaline on 
blood flow might vary from one tissue to another found in the spinal canal, e.g., epidural fat, 
epidural veins, and dura mater. The effects of adrenaline on blood flow are concentration dependent 
and it may not achieve sufficient concentrations in the epidural fat to produce vasoconstriction. In 
fact, adrenaline being hydrophilic might be present in such relatively low concentrations in the 
epidural fat that it rather causes vasodilation through β2-adrenergic receptors [Bernards et al. 2003; 
Millet et al. 1998].  
Limited data is available regarding the types of adrenoreceptors in the vessels of the epidural 
space (epidural venous plexus and vessels of epidural fat tissue) [Guimaraes and Moura 2001]. It 
may well be that there is a lack of direct experimental proof on the response of the epidural vascular 
meshwork to adrenaline.   
Furthermore, the total effect of adrenaline on CEA appears more difficult to predict when one 
takes into account the characteristics of the opioid (e.g., lipophilicity) and the local anaesthetic 
(e.g., vasoconstrictive properties) used in the epidural infusion. Ropivacaine is a lipophilic drug, 
though less so than bupivacaine which was used by Niemi and Breivik in their original study on 
adrenaline and TEA [Niemi and Breivik 1998]. Moreover, ropivacaine may have its own 
vasoconstrictive capacity, when, for example, administered intradermally [Cederholm et al. 1994], 
epidurally [Dahl et al. 1990], or intrathecally [Kristensen et al. 1998].    
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Plasma concentrations of epidurally administered ropivacaine and fentanyl 
The protocol of Study I did not take into account plasma samples of patients whose rate of epidural 
infusion required adjustment and thus were removed from the analysis of plasma drug 
concentrations. When these individuals were added to the drop-outs for other reasons, the number 
of patients contributing to plasma concentration data fell considerably (Figure 2 in Study I); caution 
is therefore necessary when interpreting these measurements. 
It seemed that although adrenaline initially produced a slight reduction in the ropivacaine 
plasma concentration, the effect was no further detected 24 and 48 h after the start of the epidural 
infusion. The small difference in plasma concentrations at 6 h did not correlate with an 
improvement in pain relief. A similar temporary effect on local anaesthetic plasma concentrations 
has been demonstrated in earlier trials where adrenaline, used as an epidural adjuvant, decreased 
plasma lidocaine concentrations for only one to two hours after the start of epidural lidocaine 
infusion [Kihara et al. 1999; Miyabe et al. 2002]. Tachyphylaxis to the vasoconstrictive effect of 
adrenaline may explain this phenomenon. A further explanation for lower ropivacaine plasma 
concentrations might be because systemically absorbed adrenaline stimulates cardiac output and 
thus increases the volume of distribution, hepatic uptake, and renal excretion of ropivacaine 
[Sharrock et al. 1991]. However, the addition of adrenaline to CEA did not effect the systemic 
blood circulation with respect to the haemodynamic parameters measured in Studies I and II.  
Fentanyl plasma concentration was not influenced by the addition of adrenaline which is in 
accordance with earlier findings [Cohen et al. 1992]. This, however, contrasts with results from a 
TEA study where the delayed systemic absorption of fentanyl was attributed to a vasoconstrictive 
effect of adrenaline [Niemi and Breivik 1998]. The anatomical differences between the lumbar and 
thoracic epidural space may contribute to these inconsistent findings.  
Summary on adrenaline as an adjuvant to LEA 
The results of Study I and II were gathered under strict circumstances and caution must be taken 
when extrapolating the data to other settings and drug combinations. One, however, can infer that 
under the conditions of Study I and II the addition of adrenaline to LEA is not recommended.  
Clonidine 
Effects on efficacy and side-effects of CEA 
After TKA in Study III, the addition of the low-dose clonidine to CEA augmented the relief of pain 
without any signs of clonidine induced haemodynamic instability or sedation. In comparison to 
earlier studies, the clonidine dosage applied (2 µg/ml, on average 9 µg/h, approximately 220 µg/d) 
can be taken as a low-dose. Higher doses of clonidine given for postoperative analgesia regularly 
caused hypotension, bradycardia, and sedation [Mogensen et al. 1992; Paech et al. 1997; Armand et 
al. 1998].  
Several parameters pointed towards an intensification of CEA by clonidine. Group RFC 
patients, on average, required less epidural drugs as compared to patients from Group RF. Improved 
pain relief in Group RFC can be deduced as well from the lesser frequency of breakthrough pain 
episodes at rest. However, the median difference in oxycodone consumption was only 3 mg during 
24 h and the lower 95% confidence limit of this difference was zero (95% CI 0–7 mg). In all, there 
was no major clinical benefit by adding the low-dose clonidine to the CEA mixture of ropivacaine 
and fentanyl when combined with a multi-modal analgesic regimen including regular paracetamol 
and rofecoxib.  
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Unfortunately, the somewhat reduced opioid requirement in Group RFC was not accompanied 
with fewer side-effects such as PONV. An emetic potential of α2-adrenergic agonists has been 
described in animal research and veterinary medicine [Japundzic-Zigon et al. 1997]. On the other 
hand, α2-adrenergic agonists seem promising allaying PONV in humans [Oddby-Muhrbeck et al. 
2002; Khasawinah et al. 2003].  
The present data does not reliably reveal whether pain relief significantly differed between the 
two TKA studies (II and III). VAS pain scores tended to be higher in Group RFA than in Group 
RFC, particularly in the early postoperative period (Figure 7 and Figure 8). However, several 
factors related to the design of the studies forbid a closer comparison – epidural top-ups were given 
in Study II but not in Study III and the drug concentrations of ropivacaine and particularly fentanyl 
(3 and 5 µg/ml in Study II and III, respectively) differed. 
Despite its limited effect on analgesia, the triple combination used for CEA in Group RFC may 
have a potential as a second line of treatment when the routine mixture of local anaesthetic and 
opioid are insufficient to control breakthrough pain or when a multi-modal analgesic regimen is not 
feasible (e.g., contraindication to NSAIDs).  
Choice of ‘optimal’ drug combination 
When planning a trial concerning adjuvant drugs, one aspect is to choose the ‘optimal’ combination 
of drugs and their concentrations. Two combinations with presumably similar potency may vary 
considerably with regard to their side-effect profiles. This difficulty has been addressed in a study 
regarding TEA [Curatolo et al. 2000] (Table 3) and in another with LEA [Sveticic et al. 2004] 
(Table 4). Interestingly, the last combination shown in Table 4 corresponds well to that used in 
Group RFC (Table 25). The drug combination of Group RFC was not based on the study by 
Sveticic et al. Rather, the dose of clonidine was selected on the premise that it would be, on 
average, lower than 20 µg/h which was the smallest dose used in previous studies and found to be 
associated with hypotension [Mogensen et al. 1992; Paech et al. 1997]. The other components of 
the CEA regimen in Study III were based upon the routine used in the particular clinic. 
 
Table 25. Comparison of drug mixture used in Group RFC of Study III with results coming from an optimization 
procedure searching for optimal drug combinations for LEA [Sveticic et al. 2004]. 
 Group RFC in Study III ’Combination 4’ in [Sveticic et al. 2004] 
Infusion rate (ml/h) 3–7 ml/h 7–15 ml/h 
Local anaesthetic concentration Ropivacaine 2.0 mg/ml Bupivacaine 0.5 mg/ml 
Fentanyl (µg/ml) 5.0 µg/ml 2.4 µg/ml 
Clonidine (µg/ml) 2.0 µg/ml 1.0 µg/ml 
RFC=Mixture of ropivacaine, fentanyl, and clonidine. LEA=Continuous postoperative epidural analgesia at lumbar 
level. ‘Combination 4’=Refers to Table 4. The two combinations correspond to each other well with a factor of 2 for 
infusion rate, fentanyl, and clonidine; and a factor of 2 times 2 for the local anaesthetics. 
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CSA and CSPA 
The spinal catheter technique used for CSA and CSPA in Study IV provided good intraoperative 
haemodynamic control and satisfactory postoperative analgesia. The patients’ overall satisfaction 
with CSPA was good to excellent. The hypothesis, however, that the infusion of low-dose 
ropivacaine (maximum 1 mg/h) and morphine (maximum 8 µg/h) would result in less motor 
blockade than ropivacaine alone (maximum 2 mg/h) was not supported.  
CSA 
The onset of CSA was slow in many instances. One-third of the patients experienced some level of 
pain at skin incision although the spread of anaesthesia appeared sufficient before the start of 
surgery as judged by the loss of cold sensation to at least T10. These situations were, however, 
readily overcome by supportive measures such as small doses of intravenous opioid, neuraxial top-
ups, and/or infiltration anaesthesia. The need for such supportive measures should not be 
considered a failure of the primary regional anaesthesia technique. The evaluation of the spread of 
CSA is known to be difficult. In a study where small increments of bupivacaine 5 mg/ml were 
given for CSA and sensory block was assessed by pinprick, a slow onset of the spinal block and the 
occurrence of pain during incision were noted [Pitkänen et al. 1992a]. The adequacy of anaesthesia 
may be improved by increasing the initial intrathecal dose. Similar problems in assessing the block 
have been described during CEA with pin-prick and the loss to cold sensation correlating only 
weakly to the degree of analgesia [Curatolo et al. 1999].  
In Studies I and IV, the average time for arterial bypass surgery of the lower extremities was 
approximately 3 h, but often even considerably longer. The use of CSA technique provided a 
sufficient length of anaesthesia in Study IV. Top-ups were needed to comparable degrees in Study I 
and IV: 26 of 44 patients receiving intrathecal top-ups after the first hour of CSA (IV) as compared 
to 26 of 45 patients requiring epidural top-ups (I). In Study IV, three patients moved their legs to 
such an extent that it interfered with surgery. This particular parameter had not been taken into 
account during Study I.  
As expected, arterial blood pressure and heart rate decreased during the first 60 min of spinal 
anaesthesia. These changes, however, were minor to moderate with no sudden deterioration in 
haemodynamic stability. Vasoactive drugs were rarely needed and, if so, in small doses. Whether 
CSA causes less haemodynamic changes as compared to SSA has been debated with reports in 
favour [Sutter et al. 1989; Morrison et al. 1991; Klimscha et al. 1993; Favarel-Garrigues et al. 
1996] and against [Pitkänen et al. 1992a; Sabaté et al. 1994; Lundorff et al. 1999]. Since not all 
these studies were carried out for peripheral artery graft surgery, they are not directly comparable to 
Study IV. Some of the inequalities noted between Study IV and other trials [Morrison et al. 1991; 
Sabaté et al. 1994; Lundorff et al. 1999] might be explained by methodological aspects, as for 
example, various co-existing diseases [Sabaté et al. 1994]; whether invasive CVP control was used 
or not [Morrison et al. 1991; Lundorff et al. 1999]; and if the first dose of local anaesthetic was 
given while the patient was still in the sitting position [Lundorff et al. 1999] or only when placed in 
the supine position after lumbar puncture.   
When re-operation for reasons of haemorrhage was needed in the four patients of Study IV, 
spinal anaesthesia was easy to achieve again by injecting small amounts of local anaesthetic 
through the catheter. This proved advantageous for both the patient and the anaesthetist, as no 
further anaesthesia technique was needed. 
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CSPA 
Pain relief was adequate in both groups of Study IV with no clinically significant difference in the 
amount of oxycodone as rescue medication. Perhaps some patients would have benefited from 
slightly higher infusion rates with respect to pain relief, but it was decided not to exceed the rate of 
0.4 ml/h, as experience with the CSPA technique in vascular surgery patients was limited. The 
infusion rate was reduced at least on one occasion in nearly half of the patients (20/44). This was 
done to counteract the moderate hypotension and in some instances for the pronounced motor 
blockade. However, there were no treatment-resistant periods of hypotension and the infusion rate 
was re-instated once haemodynamic stabilization was again established.   
Ropivacaine was chosen as spinal anaesthetic in Study IV because it is associated with less 
motor blockade than bupivacaine which was the local anaesthetic used earlier for CSA and CSPA 
[Van Gessel et al. 1995; Standl et al. 1995a; Niemi et al. 1996; Bachmann et al. 1997; Vercauteren 
et al. 1998; Maurer et al. 2003; Gurlit et al. 2004]. Indeed, the degree of motor blockade was 
minimal throughout the entire CSPA study period (Figure 2 in Study IV) with three patients of 
Group R and one of Group RM displaying a motor blockade grade 1 on Day 1. Unfortunately, no 
conclusion can be reached regarding a possible difference between the Groups R and RM. Yet, the 
motor blockade appeared to be less marked in this study with ropivacaine as compared to that with 
bupivacaine [Bachmann et al. 1997]. Whereas slightly more than 10% of the patients had a 
modified Bromage score of 2 after 4 h from the start of CSPA with ropivacaine in Study IV, more 
than 70% of them manifested a score of 2 or 3 measured 3 h after the start of CSPA with 
bupivacaine (either bupivacaine 2 mg/h or bupivacaine 1mg/h plus morphine 8 µg/h) [Bachmann et 
al. 1997]. An RCT directly comparing bupivacaine and ropivacaine in CSPA is needed to confirm 
whether these two local anaesthetics differ as to their analgesic efficacy and their potential to 
produce motor blockade.  
The amounts of ropivacaine given for CSA intraoperatively and the consumption of 
intrathecally infused drugs during CSPA were somewhat larger in Group RM than in Group R. 
Although statistically significant, both these differences were, clinically speaking, small and the 
corresponding lower 95% confidence limits approached zero: The median difference of ropivacaine 
for CSA was 7.5 (95% CI 0–11.3) mg and the median difference of intrathecally infused drugs 
during CSPA was 0.4 (95% CI 0.04–0.7) ml. Most likely, both of these differences had little or no 
influence on pain scores or on the degree of motor blockade in the postoperative period.  
The combination of low-dose ropivacaine and morphine was not better than the higher 
ropivacaine dose alone. In a previous study [Bachmann et al. 1997], bupivacaine 1 mg/h combined 
with morphine 8 µg/h provided satisfactory CSPA, as did bupivacaine 2 mg/h after hip and knee 
arthroplasty. However, Bachmann et al. concluded that the combination was desirable because it 
produced less motor blockade. The small dose of intrathecal morphine given to patients in Group 
RM did not lessen the need for oxycodone during the 24 h following CSPA, i.e., there was no carry-
over effect of the intrathecal morphine.  
No reliable conclusion can be drawn from the data concerning the question as to whether pain 
scores were higher during CSPA when compared to CEA in Study I (Figure 6) because the two 
trials were not designed to undergo a direct comparison.  
As stated above, CEA may have beneficial effects on graft patency after arterial bypass surgery 
(Table 2). This outcome parameter was not part of Study I and IV. It remains open as to whether 
CSPA might provide a similar advantageous consequence on graft performance as does CEA.  
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EST  
EST was often cumbersome to perform and the identification of the motor response threshold next 
to the interpretation of the test results were several times complicated. Neither did EST help to 
identify the four patients whose catheters were outside the spinal canal preoperatively. On the other 
hand, it did correctly detect the single case of intrathecal catheter location. During most of the 
measurements with an epidurally positioned catheter tip, EST elicited twitching despite the 
preceding or simultaneous administration of epidural local anaesthetics.   
After its original description [Tsui et al. 1998], EST has been part of numerous reports [Tsui et 
al. 1999c; Tsui et al. 1999b; Tsui et al. 1999a; Tsui et al. 2000; Goobie et al. 2003; Tsui et al. 
2004a; De Medicis et al. 2005; Tsui et al. 2007; Charghi et al. 2007]. Study V corroborated some of 
the earlier findings but has also linked EST to several difficulties previously not described. 
Catheter tip epidurally or outside of spinal canal 
EST1 produced a motor response in all patients including the four from Subgroup Paravert. In the 
latter, twitching thresholds were slightly below or above 8 mA. It has been suggested that if motor 
response is seen at a current between 8 and 10 mA, the motor response should change in terms of 
strength or location when the grounding electrode is relocated [Tsui et al. 1998]. This double-check 
method did not uncover the paravertebral catheter position in the two patients with EST1 at 8.2 and 
8.9 mA. One false negative EST1 occurred at 10.5 mA; this level of current approaches the 10 mA 
initially suggested to be the limit for distinguishing between epidural and non-epidural catheter 
positions [Tsui et al. 1998]. Interestingly, Tsui recently stated that currents above 10 mA are quite 
often needed [Tsui 2006]. However, it remains unclear as to where to place the upper cut-off, at 10 
mA [Tsui et al. 1998], 11.1 mA [Goobie et al. 2003], or even 15 mA [Tsui 2006].  
Catheter tip intrathecally or on a nerve root 
The lower limit <1 mA is always to be considered as a warning sign for the possible subtotal or 
subarachnoid catheter position [Tsui et al. 1998; Tsui 2006]. This concept [Tsui et al. 1998; Tsui et 
al. 1999a; Tsui et al. 2004b; Lena and Martin 2005; Tsui et al. 2005b] is supported by the findings 
from the patient with dura tap in Study V where bilateral twitching began at 0.6 mA and grew 
obviously in strength at 0.7 mA. Indeed, a suspicion of a dura tap was linked with the spontaneous 
and constant back-flow of a clear fluid through the catheter. However, appearance of cerebrospinal 
fluid is not a matter of course in such a situation and there are reports of intrathecal drug 
administration in spite of a negative aspiration test [Tsui et al. 1999a].  
The original EST description stated that a situation where the catheter is epidurally but directly 
against a nerve root may result in a motor response <1 mA [Tsui et al. 1998]. It has been debated 
whether such a condition (against-nerve-root-position, unilateral, segmental twitching combined 
with a negative aspiration test) should be taken as a negative rather than a positive EST test result 
[Tsui et al. 1998; De Medicis et al. 2005; Tsui 2006]. Such unilateral, segmental responses at <1 
mA were encountered in two patients during EST1 in Study V. 
EST as a monitor of catheter location during CEA 
On average, an increase in milliamperage was needed to produce a motor response following the 
injection of local anaesthetic (Figure 10). This observation is in agreement with previous studies 
[Tsui et al. 1999b] and has been promoted as a possible tool to monitor the clinical effect of 
repeated epidural local anaesthetic [Tsui et al. 1999b]. Whether EST might be a useful measure to 
ensure the position of the catheter during CEA remains unanswered from Study V. There are, at 
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least, several observations which give reason to doubt this: a) the lower thresholds in some patients 
following epidural local anaesthetic; b) the Category of motor response or the site of motor 
response within a Category unpredictably changed from one EST to another; c) the false positive 
EST results; and d) the false negative EST results during CEA on several occasions (no motor 
response during EST2-5, Figure 10). One possible reason for these observations is that when the 
patient moves, the soft catheter tip bends within the epidural space and this, in turn, may greatly 
influence the threshold and the site of response. Yet, when EST6 was performed some 2 h after the 
termination of CEA, consisting of a low-dose opioid-local anaesthetic infusion, a positive EST 
result was observed in all 22 individuals having an epidurally situated catheter (Figure 10). This 
indicates that EST might be helpful in verifying a possible catheter dislodgment during CEA.  
Interpretation of the sensory response 
The heterogeneous results from Study V show that questioning the patients for the sensory response 
to EST only decreases the diagnostic accuracy of EST. This is in contrast to an earlier assertion 
suggesting that the overall sensitivity of EST might be increased by including subjective sensory 
responses [De Medicis et al. 2005]. 
EST and quality of CEA  
All 25 patients receiving CEA had sufficient pain relief as assessed by PHH-scores, VAS pain 
scores, and rescue medication requirement over the first two postoperative days. Whether EST 
contributed to this remains unclear. CEA failures due to initially misplaced catheters would have 
occurred without epidurography. 
Promising EST performance results were found in earlier studies which compared EST with 
other indirect methods [Tsui et al. 1998; De Medicis et al. 2005; Charghi et al. 2007]. These are 
difficult to compare to the present results which have been based on a direct confirmation method, 
i.e., epidurography. For example, evaluating sensory blockade following a local anaesthetic test 
dose [Tsui et al. 1998; De Medicis et al. 2005; Charghi et al. 2007] includes subjectivity on both 
the side of the patient and of the investigator. Besides, whereas in Study V the catheter positions 
were traced systematically from the moment of catheter placement until the second postoperative 
day, earlier studies only focused on previously placed epidural catheters [Tsui et al. 1998; Tsui et 
al. 1999a; Tsui et al. 2000] or on the time of catheter placement [Tsui et al. 1999b; Goobie et al. 
2003; Tsui et al. 2005a]. Other methodological differences are also apparent. In Study V, the 
efficacy of CEA was evaluated systematically until Day 2. Other reports on the efficacy of epidural 
postoperative analgesia, however, were either incomplete [De Medicis et al. 2005; Charghi et al. 
2007], or included data gathered from very young children who would be unable to express in detail 
the effectiveness of a particular pain treatment regimen [Tsui et al. 2001; Tsui et al. 2004a]. In 
some studies, confirmation was attempted with an anteroposterior X-ray but without contrast 
medium [Tsui et al. 2001; Goobie et al. 2003; Tsui et al. 2004a; Tsui et al. 2006; Tsui et al. 2007]. 
Although epidurography is far from being a routine technique, it was used as the reference 
diagnostic test in Study V. 
There is no blinded RCT yet available in which the influence of EST on the efficacy of 
postoperative epidural analgesia had been investigated. Goobie et al. carried out an open trial of 30 
paediatric patients who received a thoracic epidural catheter inserted under general anaesthesia. 
They stated that the addition of EST was of no benefit when used with directly placed epidural 
catheters [Goobie et al. 2003].
Technical and methodological aspects 
It remains speculative as to why previous studies did not report difficulties in performing EST such 
as the frequent need for saline flushing, the influence of respiratory cycle on the often barely visible 
motor response, and that often the maximum output of the neurostimulator did not reach the 
implicit 16 mA. Another possibility might be insufficient experience with the EST technique; 
however, when dealing with an alleged simple method one might expect the learning curve to be 
steep and short. The investigators were aware of the epidurography results when performing EST4–6 
in Study V. This is in par with earlier studies in which the researchers were also not blinded to 
results of the comparator method [Tsui et al. 1998; De Medicis et al. 2005; Charghi et al. 2007]. 
Finally, the findings of Study V must be interpreted with caution because of the small number of 
patients studied.  
Complications, side-effects, and technical problems 
Due to the small patient population investigated, Studies I–V provided only limited data to 
determine the association between the continuous neuraxial techniques and the postoperative 
complications and side-effects such as PONV, postoperative confusion, and head- and backache. 
However, the incidence of PONV, for example, is comparable to the results of meta-analyses 
[Block et al. 2003; Dolin and Cashman 2005]. PONV can be partly attributed to the opioids added 
to the drug infusions used for CEA and CSPA, as well as to those used as rescue medication [Block 
et al. 2003; Dolin and Cashman 2005]. Results from Study IV confirm that PDPH does not pose a 
major problem of CSA, particularly in the elderly and in conjunction with CSPA [Denny et al. 
1987; Mahisekar et al. 1991]. Postoperative confusion-delirium may be often encountered in the 
older patient and following major orthopaedic surgery [Williams-Russo et al. 1992; Bekker and 
Weeks 2003].  
The rate of complete CEA failures from the initiation of treatment was about 5% (9/192 Studies 
I–III, Table 15). In retrospect, when adding to this amount the two patients who were prematurely 
excluded because of insufficient CEA (see text on page 42), as well as the four patients of Subgroup 
Paravert (Table 23) who were at risk of experiencing an unsuccessful CEA, then the total CEA 
failure rate would rise to 7% (15/217, Table 16). Unfortunately, in Studies I–III, the number of 
CEA failures arising from a misplaced catheter was not an investigated parameter. In Study V, four 
of the 40 catheters were initially located outside the spinal canal. This incidence is similar to that 
seen in an investigation where the rate of patients with unrecognized incorrect placement of 
thoracic epidural catheters was 10%–15% [Rigg et al. 2002]. Premature epidural catheter 
dislodgement was observed in almost 3% of CEA treatments (6/217). In earlier trials, this incidence 
has been somewhat higher, 6%–12% [Scott et al. 1995; Dolin et al. 2002].  
The success-failure ratio of CSA in Study IV is comparable to the results from a large 
prospective study where failure rates were 1.0% and 1.5% for SSA and CSA, respectively 
[Puolakka et al. 2000a]. The CSPA technique was not free of obstacles, e.g., catheter kinking and 
leakage at the site of the catheter adapter connection. Nevertheless, these problems were overcome 
and did not cause any exclusion in the 44 CSPA patients in Study IV.  
CEA and CSPA involve interventions and devices and as such are prone to technical problems. 
Such difficulties were encountered during the studies here to degrees which are comparable to 
previous reports [Silvanto et al. 1992; Pitkänen et al. 1992b; Niemi et al. 1994; Scott et al. 1995; 
Ready 1999; Puolakka et al. 2000b]. These problems include difficulties met when applying 
prolonged neuraxial analgesia through an indwelling catheter and when using medical mechanical 
devices. For example, leakage at some point of the catheter-adapter-infusion line, disconnection of 
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the catheter from the adapter, catheter kinking, premature catheter dislodgement, and infusion pump 
failure were noted. The technical problems, however, did not lead to any apparent harm in any of 
the patients.  
Limitations of Studies I–V 
Only a single-dose of the α2-adrenergic agonists adrenaline and clonidine was investigated in each 
of the Studies I–III which can be regarded as a limitation. Had the study protocols included a larger 
range of drug concentrations the results would have had a wider applicability.  
Studies I–IV did not take into account whether CEA and CSPA affected long-term outcome 
variables such as the quality of recovery of the operated leg, hospital discharge times, and 
resumption of normal activities of daily living. For example, it would have increased the value of 
Study IV to examine whether CSPA would have any preventive effect on the development of 
neuropathic pain after peripheral vascular surgery [Greiner et al. 2004].   
Limitations of Study V are debated above under the heading: EST – Technical and 
methodological aspects.  
Future research 
Adrenaline 
Further basic research is required as concerns the epidural vascular meshwork and its reactivity to 
adrenoceptor agonists. It would be of utmost interest to measure drug concentrations directly from 
the epidural space in humans in analogy to the microdialysis technique used in animals [Bernards et 
al. 2003]. Future studies on adrenaline as an adjunct to CEA should take into account the dose-
effect relationship and the influence of a bolus administration versus a continuous infusion. 
Clonidine 
Future investigations with clonidine as an adjuvant to local anaesthetics and opioids for CEA 
should employ various concentrations of clonidine. In that respect, when contemplating study 
designs with higher complexity in the future the results from investigations such as the optimization 
procedure studies (see above under the heading: Clonidine – Choice of ‘optimal’ drug combination) 
[Curatolo et al. 2000; Sveticic et al. 2004] should be considered.  
Triple combinations of clonidine, local anaesthetic, and opioid have been studied also in 
conjunction with intrathecal pain management [Grace et al. 1995; Paech et al. 2002; Sites et al. 
2003]. In these studies, clonidine was given in boluses of up to 75 µg. Although such single-dose 
methods do not require spinal or epidural catheters, they do bear the risk of significant hypotension 
[Grace et al. 1995; Paech et al. 2002; Sites et al. 2003]. Therefore, it might be of interest to study 
the administration of a low-dose combination of clonidine, opioid, and local anaesthetic using the 
CSPA technique. 
CSA/CSPA versus SSA/CEA 
An RCT comparing the CSA/CSPA technique with the SSA/CEA method given for peripheral 
arterial bypass surgery seems warranted. Such a study could address several of the questions raised 
in Studies I and IV: a) the intraoperative haemodynamic stability particularly in the early phase of 
anaesthesia; b) the degree of intraoperative motor blockade and its influence on surgical conditions 
specially in the later phase of the operation, i.e., during anastomosis of the vessels; c) the efficacy 
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and tolerance of postoperative analgesia and its possible effects on outcome, e.g., mobilization, 
graft patency, and development of chronic pain.  
EST 
While EST could not increase the confidence of providing effective CEA in Study V, the results do 
not allow the abolishment of the EST technique together with many of its potential benefits 
mentioned in the literature. Only recently, after the completion of Study V, a new catheter set 
(StimuLong Tsui Method®, Pajunk GmbH, Geisingen, Germany) for plexus and epidural 
anaesthesia was marketed. Due to certain properties this catheter may facilitate to perform EST 
without an additional adapter (Johans ECG adapter®, Study V) and without the need to flush the 
catheter. Thus, it might improve the feasibility and reliability of the test. Future EST studies should 
address such equipment-related issues in addition to the study design considerations mentioned 
earlier in this discussion (randomized, controlled, blinded trial; EST both at the time of catheter 
placement and repeatedly during CEA).  
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Conclusions 
1. Adrenaline, in concentrations of 2 µg/ml and 4 µg/ml, failed to contribute to the efficacy or 
tolerability of lumbar continuous epidural analgesia when added to low-dose infusion of 
ropivacaine and fentanyl after arterial bypass leg surgery and following total knee arthroplasty, 
respectively. Thus, the use of adrenaline as an adjuvant to lumbar continuous epidural analgesia 
cannot be recommended under the circumstances of Studies I and II.  
2. The adjuvant clonidine provided only slightly enhanced pain relief of lumbar continuous 
epidural analgesia when infused in doses of 6–14 µg/h together with a low-dose ropivacaine-
fentanyl mixture after total knee replacement. In these low doses, clonidine had no beneficial, 
but also no marked detrimental consequences on the side-effect profile of the pain treatment 
regimen. Hence, the triple combination with clonidine may be considered as a second line 
treatment. 
3. The continuous spinal anaesthesia technique utilizing a 28G microcatheter proved useful for 
arterial bypass surgery of the lower extremities. The main advantages were stable intraoperative 
haemodynamic control, ease of topping-up during prolonged surgery, as well as the ease of 
providing for spinal anaesthesia when revision surgery became necessary. Continuous spinal 
postoperative analgesia through the spinal catheter, already in place, provided adequate pain 
relief. Nevertheless, these results should be corroborated and directly compared to the 
combination of single-dose spinal anaesthesia and continuous epidural analgesia.  
4. The epidural stimulation test, which has been earlier introduced as a simple and reliable method 
to verify the epidural catheter position, was found here to be more difficult to perform than 
expected and was associated with problems of interpretation. It was not helpful for the accurate 
determination of the epidural catheter position at the moment of its placement nor when applied 
repeatedly during the course of continuous epidural analgesia. The possible role of the epidural 
stimulation test in quality assurance of continuous epidural analgesia remains to be established. 
5. The incidences and types of technical problems during continuous epidural and spinal 
anaesthesia and analgesia encountered in Studies I–V are comparable to those of earlier reports. 
Unrecognized erroneous placement of epidural catheters and changes of the catheter tip position 
to less favourable sites (e.g., slipping out of the epidural space but still remaining in situ) during 
continuous epidural analgesia are everyday challenges in the clinical arena. An easy-to-use and 
reliable test for the identification of such situations remains to be developed. 
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Errata 
Table 1 of Study I, page 1108, gives incorrect data for type of bypass were presented. The correct 
figures are presented here, in Table 18, page 46. 
On page 398 of Study IV the symbol “≤” was omitted. This should read “Sedation scores were ≤1 
in all but one patient, who had a score of 3.” 
 
 
